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Factors Influencing The Receipt Of Discharge Pain Treatment By Injured Black
Patients
Abstract
Undertreated pain can negatively influence outcomes in seriously injured patients. The current United
States (US) opioid crisis has impacted prescribing practices. Concurrently, research has documented
racial disparities in pain treatment for a variety of conditions, with Black patients less likely than White
patients to receive pain treatment in emergency department and out-patient settings. However, research
focused on differences in pain treatment among Black patients with acute injuries requiring
hospitalization is lacking, as is literature that explores the factors providers consider when planning
discharge pain treatment for severely injured patients. The aims of this multi-methods dissertation study
were to synthesize the existing literature about the factors that impact the receipt of pain treatment by
injured Black patients, to quantitatively describe the factors that predict the discharge opioid
prescriptions in a cohort of seriously injured Black men, and to qualitatively explore the factors that
providers take into consideration when prescribing discharge pain medications for seriously injured
patients. A secondary analysis of data from the Psychological Effects of Injuries in Injured Black Men
Study (ERRI) was used to describe the factors that predict discharge opioid prescriptions in a cohort of
Black men hospitalized with serious injury. Injury severity, pain severity, length of stay (LOS) and selfreported substance overuse were associated with receipt of opioids at discharge. Among patients who
received opioids, pain severity and LOS were associated with increasing dosages. Providers were
interviewed using a semi-structured interview guide to explore the factors that they take into
consideration when planning discharge pain treatment for seriously injured patients. Providers voiced the
need to determine “true” pain and described reliable methods for doing so. They expressed concern about
increased risk of opioid misuse and diversion in their patient population, and discussed the
consequences of not getting it right with regards to determining which patients require pain treatment.
While these findings suggest that receipt of opioids in the ERRI cohort was associated with injury and
pain severity, LOS, and possibly substance overuse history, provider decision-making regarding discharge
opioids is complex and likely related to issues of trust, especially in the age of the current opioid crisis.
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ABSTRACT
FACTORS INFLUENCING THE RECEIPT OF DISCHARGE PAIN TREATMENT
BY INJURED BLACK PATIENTS
Shoshana V. Aronowitz
Therese S. Richmond
Undertreated pain can negatively influence outcomes in seriously injured patients. The
current United States (US) opioid crisis has impacted prescribing practices. Concurrently,
research has documented racial disparities in pain treatment for a variety of conditions,
with Black patients less likely than White patients to receive pain treatment in emergency
department and out-patient settings. However, research focused on differences in pain
treatment among Black patients with acute injuries requiring hospitalization is lacking, as
is literature that explores the factors providers consider when planning discharge pain
treatment for severely injured patients. The aims of this multi-methods dissertation study
were to synthesize the existing literature about the factors that impact the receipt of pain
treatment by injured Black patients, to quantitatively describe the factors that predict the
discharge opioid prescriptions in a cohort of seriously injured Black men, and to
qualitatively explore the factors that providers take into consideration when prescribing
discharge pain medications for seriously injured patients. A secondary analysis of data
from the Psychological Effects of Injuries in Injured Black Men Study (ERRI) was used
to describe the factors that predict discharge opioid prescriptions in a cohort of Black
men hospitalized with serious injury. Injury severity, pain severity, length of stay (LOS)
and self-reported substance overuse were associated with receipt of opioids at discharge.
Among patients who received opioids, pain severity and LOS were associated with
vi

increasing dosages. Providers were interviewed using a semi-structured interview guide
to explore the factors that they take into consideration when planning discharge pain
treatment for seriously injured patients. Providers voiced the need to determine “true”
pain and described reliable methods for doing so. They expressed concern about
increased risk of opioid misuse and diversion in their patient population, and discussed
the consequences of not getting it right with regards to determining which patients
require pain treatment. While these findings suggest that receipt of opioids in the ERRI
cohort was associated with injury and pain severity, LOS, and possibly substance overuse
history, provider decision-making regarding discharge opioids is complex and likely
related to issues of trust, especially in the age of the current opioid crisis.
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Chapter 1
Introduction
Undertreated pain has a myriad of negative consequences. Individuals suffering
from untreated or undertreated pain can experience negative physical, mental, social, and
financial outcomes; they may engage in illicit or risky behavior in an attempt to selfmedicate, and their quality of life may be seriously diminished (Alford et al, 2016;
Institute of Medicine, 2011; Volkow & McLennan, 2016). According to the Institute of
Medicine’s (IOM) Unequal Treatment report, which addresses racial disparities in health
care, there are systematic differences in the way patients are treated for pain (2003). In
particular, Black patients are more likely to be undertreated for traumatic, surgical, and
chronic pain and are less likely to be prescribed opioids than White patients (Meghani,
Byun & Gallagher, 2012). Adding to the complexity of pain treatment is the current US
opioid crisis, contributing to as many as 130 overdose deaths per day (Centers for
Disease Control, 2017). While the opioid crisis is often portrayed as an issue
predominately impacting White communities, recent data reveal that overdose rates have
rapidly increased among people of color since 2011 (Spencer et al., 2019). However,
White Americans still have the highest overdose death rates of all racial groups (Spencer
et al., 2019).
Despite a lack of data to suggest that Black people are more likely to abuse
opioids than are White people (Substance Abuse and Mental Health Services
Administration, 2014), there is evidence that providers believe that Black patients are at a
higher risk for opioid misuse and addiction (Becker et al., 2011; Netherland & Hansen,
2017). This may lead to undertreatment of pain as well as higher levels of suspicion about
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potential for misuse and diversion of medications (Becker et al., 2011). Disparities in pain
treatment by race or ethnicity highlight the presence of ongoing racism and
discrimination in healthcare, which is a serious ethical issue that requires attention.
Research that focuses on the impact of injury intent (i.e. intentional such as
gunshot wound vs. unintentional such as motor vehicle crash) on pain treatment is
lacking. Providers may be suspicious of patients who are injured intentionally and
assume that they had participated in criminal activity that caused or contributed to their
injuries (Martin, 2000; Patton et al., 2016; Rich, 2009). It is possible that intent of injury
may impact pain treatment out of concern that intentionally injured patients are involved
in drug-related criminal activity, or that their possible involvement in crime might
increase the likelihood that they would misuse or divert medication. Intent of injury may
also impact the empathy that providers extend to patients, as providers may assume that
intentionally injured patients “did something” to warrant their injuries (Patton, et al.,
2016; Rich, 2009). Likewise, a history of substance use may also have an impact on pain
treatment, since providers may fear that people will misuse or divert prescribed
medications (Sinnenberg, et al., 2017). Pain medications given while a patient is
hospitalized can be closely monitored, but providers lose this degree of control when
patients leave the hospital and the perceived possibility of misuse of discharge opioid
prescriptions factor into providers’ discharge planning.
The purpose of this multi-methods dissertation study was to synthesize the current
literature regarding the receipt of pain treatment by injured Black patients, quantitively
describe the factors that are associated with receipt of discharge opioid prescriptions in a
cohort of seriously injured Black men and to qualitatively explore what factors providers
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take into consideration during discharge planning for seriously injured patients. The
mixed-studies review presented in Chapter 2 contributed to the development of a
theoretical model (see Figure 2.1) describing post-injury pain treatment provider
decision-making. This model addresses the impacts of injury characteristics, patient
characteristics, setting characteristics, provider characteristics, provider assumptions, and
clinical judgment on discharge pain treatment post-hospitalization for acute injury.
Although not explicitly addressed in this model, provider assumptions about patients and
their subsequent treatment decisions are influenced by the greater sociopolitical milieu.
Specific Aims and Hypotheses
1. Explore the state of knowledge regarding factors that impact the receipt of pain
treatment in injured Black patients with a mixed-studies review (Chapter 2).
2. Examine which factors predict the receipt of discharge opioid prescriptions in a
cohort of seriously injured Black men (Chapter 3).
a. Hypotheses:
i. Men with intentional injuries and substance use histories will be
less likely to be discharged on opioids than men with unintentional
injuries and no substance use histories.
ii. Of those discharged on opioids, men with intentional injury and
substance use histories will receive lower morphine equivalent
doses than men with unintentional injuries and no substance use
history.
3. Explore the factors that providers take into consideration when prescribing pain
treatment during discharge planning for seriously injured patients (Chapter 4).
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Background
The United States (US) is currently experiencing an “opioid crisis”; as many as
130 individuals die of an overdose daily, and 40 of these overdoses involve prescription
opioids (Centers for Disease Control, 2017). Although the disturbing trends of addiction
and overdose death have prompted a necessary reevaluation of pain treatment, pain is still
an extremely common problem that requires attention. One third of Americans suffer
with pain, and pain is the leading reason individuals access healthcare (National Institutes
of Health, 2010; Volkow & McLennan, 2016). In addition, race impacts the treatment
patients receive for pain (Anderson, Green & Payne, 2009; Institute of Medicine, 2003;
Meghani, Byun & Gallagher, 2012). In particular, Black patients are more likely to be
undertreated for traumatic, surgical, and chronic pain and are less likely to be prescribed
opioids than White patients, despite the fact that Black people are at no higher risk of
abusing substances than White people (Meghani, Byun & Gallagher, 2012; Netherland &
Hansen, 2017; Substance Abuse and Mental Health Services Administration, 2014). The
complexity of this issue is clear: while solutions to the opioid crisis in general are
desperately needed, disparate treatment based on race is a serious clinical and ethical
issue that also needs to be addressed.
This dissertation study adds to previous research by exploring factors associated
with receipt of pain treatment in a cohort of Black men, a group of patients already at risk
of pain undertreatment across a variety of clinical settings due to racial bias. This study
also qualitatively explores provider considerations vis-à-vis discharge pain treatment for
acutely injured patients. Research focused on the pain treatment of acutely injured Black
men is important as injury is a leading cause of morbidity and mortality in this population
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(Centers for Disease Control and Prevention, 2017; Cook et al., 2017). In addition,
qualitative studies of injured Black patients have found that they report feeling
stigmatized by healthcare providers (Jacoby, 2015; Liebchutz, 2010; Patton et al., 2016;
Rich, 2009). This study additionally provides perspectives from providers (nurse
practitioners, physician assistants, and physicians) who prescribe discharge pain
treatment for seriously injured individuals. Previous research exploring provider
decision-making regarding opioids focused on the experiences of emergency medicine
physicians (Sinnenberg, et al., 2017), whose pain treatment decision-making experiences
may differ from providers treating patients with injuries severe enough to require
hospitalization.
Pain & Pain Treatment. According to the International Association for the
Study of Pain, pain is defined as “an unpleasant sensory and emotional experience
associated with actual or potential tissue damage or described in terms of such damage”
(2017). Although commonly thought of as an unpleasant experience to be numbed
whenever possible, physical pain is a sensation that exists to benefit organisms by
alerting them to potentially damaging events. However, the existence of pain does not
always correlate with ongoing tissue damage, and pain can become pathologic, unhelpful,
chronic, and highly distressing (McCaffrey & Pasero, 1999; Ringkamp, Raja, Campbell
& Meyer, 2013). Pain experienced during the healing stages of an injury is generally
considered normal and expected but may impact a patient’s ability to heal if it interferes
with their ability to engage in healthy and healing activities such as physical therapy,
mobility, family responsibilities, and community engagement (Institute of Medicine,
2011; Lee, 2013; Volkow & McLennan, 2016).
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While the appropriateness and effectiveness of opioids to treat chronic pain are
increasingly being questioned, opioid medications remain an important tool in the
treatment of severe acute and surgical pain (Chou et al., 2016). Some evidence suggests
that the experience of severe pain post-surgery can increase the chances that a patient will
develop chronic pain (Chapman & Vierk, 2017). Lack of access to adequate pain
management may negatively impact healing and put patients at risk of self-medicating
with illicit or dangerous substances (Alford et al., 2016; Lee, 2013). Thus, adequate
management of pain post-injury with multi-modal approaches that include medication
and non-medication management is crucial.
Some experimental pain studies have reported differences in pain tolerance
between racial groups, and some findings suggest that Black patients may have lower
pain tolerance than White patients (Kim et al., 2017). A common interpretation of these
results--that there are biological differences between races causing these differences--is
highly contentious. Methods for assignment of race in research can vary widely across
studies (for example, participant self-reported race versus researcher-assigned based on
participant appearance), and greater genetic differences can be found within racial groups
than between them (Kahn, 2012; Witherspoon et al., 2007; Yudell, Roberts, DeSalle &
Tishkoff, 2016). In addition, the sociopolitical nature of race assignment causes racial
categories to change over time; some populations once viewed as non-White in the US
have “become” White, which delegitimizes the theoretical framework of race as
scientific, biological category (Roberts, 2012; Zuberi, 2003). Racial differences in health
outcomes and symptomology are instead most likely due to disparities in care and
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structural racism present in all facets of US society (Roberts, 2012; Yudell, Roberts,
DeSalle & Tishkoff, 2016).
Implicit Bias. A difficulty facing researchers attempting to evaluate the impact of
racism and bias on healthcare is the fact that many individuals, healthcare professionals
included, are unaware of their biases. Explicit bias refers to prejudiced beliefs that an
individual is aware of and can choose to keep hidden, as they are conscious of the social
unacceptability of these biases in certain environments (Maina, Belton, Ginzberg, Singh
& Johnson., 2018). Implicit bias refers to unconscious beliefs. These beliefs and attitudes
are harder to measure but are often evaluated in research studies with the Implicit
Association Test (IAT) (Maina et al., 2018, Greenwald et al., 1998). Versions of this test
exist for many different types of biases, such as race or class related biases (Maina et al.,
2018).
Studies using the IAT to determine racial bias have found that healthcare
professionals such as physicians, nurses, physician assistants, and mental health
therapists have pro-White/anti-Black biases and are more likely to associate White
patients with “cooperativeness” and “compliance” (Maina et al, 2018; Oliver et al., 2014;
Sabin & Greenwald, 2012). Black healthcare professionals are less likely than healthcare
professionals of other races to exhibit implicit bias (Maina et al., 2018).Vignette studies
exploring how these biases impact pain treatment report conflicting results; some studies
have found that pro-White implicit bias reduces the likelihood that a provider will
prescribe pain treatment to Black patients (Sabin & Greenwald, 2012), while other
studies report no association (Ashburn-Nardo & Kronke, 2015; Haider et al., 2011; Hirsh,
Hollingshead). A study focused on trauma surgeons found that while these providers
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demonstrated clear preferences for White and higher socioeconomic status patients, these
biases did not impact vignette treatment decisions (Haider et al., 2014). A major
limitation of IAT studies is the fact that most use vignettes or virtual reality to measure
the impact of implicit bias on healthcare decisions and care, and the ability of fictional
scenarios to accurately reflect real life clinical environments is questionable (Converse,
Barrett, Rich & Reschovsky, 2015; Maina et al., 2018)
Intentionality of Injury. It is possible that intentionality of injury may impact
pain treatment. In this dissertation study, intentional injury is defined as a purposefully
inflicted violent injury in which the person was harmed by another person (gunshot
wound, stabbing, assault), and an unintentional injury is one which occurs “by accident”
(motor vehicle crash, fall). Although there is a lack of research focused on injury
intentionality and pain treatment, it is possible that the “assumed criminality” of patients
by providers may occur when patients present with an intentional or violent injury.
Gunshot wounds or injuries from assaults may suggest to providers that patients were
involved in crime (despite the fact that many individuals are not involved in crime at the
time of injury), and providers may worry that these patients are more likely to engage in
risky or illicit behaviors such as misuse or diversion of opioid pain medications (Patton et
al., 2016; Rich, 2009).
Qualitative studies exploring the experiences of intentionally injured Black men
have found that these patients express feeling stigmatized by providers partially due to
their injuries (Liebschutz et al., 2010; Patton et al., 2016; Rich, 2009). In addition, a study
exploring factors that influence ED physicians’ decisions to prescribe opioids found that
the participants stated they were more likely to prescribe opioids to patients they deemed
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“trustworthy” and relatable. Some participants stated that when patients were
experiencing pain from conditions that the physicians themselves had experienced in the
past (kidney stones, for example), they were more likely to prescribe pain treatment as
they understood how painful the experience was (Sinnenberg et al., 2017). In his study of
intentionally injured young Black men, Rich states that intentional injuries can make
patients less relatable to providers since providers are unlikely to have experienced living
in neighborhoods where intentional injuries are common and can be sustained even
without involvement in crime (2009). A study focused on racial disparities in pain
treatment in the ED reported the incidental finding that patients with assault and gunshot
wound injuries were less likely to receive opioids than patients with unintentional
injuries; this difference was insignificant, possibly due to small sample size of individuals
with intentional injuries (Neighbor, Honner & Kohn, 2004).
Assumed Criminality. “Assumed criminality” refers to the belief or stereotype
that a person or group of people is likely to be involved in crime despite a lack of firm
evidence of illicit activity. Black men are more likely than other demographic groups to
be assumed criminal by society at large, regardless of actual criminal background
(Muhammad, 2011; Oliver, 2003; Owusu-Bempah, 2017). Media reports have
highlighted recent instances of White people calling the police when they witness Black
people engaging in benign, everyday activities, possibly due to a conflation of Blackness
with crime (Caron, 2018; Stevens, 2018; Taylor, 2018). Unintended consequences of
recent “ban the box” policy changes that forbid employers from asking about the criminal
backgrounds of applicants in the early stages of job applications further illustrate this
phenomenon. When employers are unable to ask about criminal background, certain
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applicants (low-skilled young Black men) are less likely to be called back for an
interview, presumably due to the fact that employers assume (without contrary evidence)
that certain individuals have criminal backgrounds (Agan & Starr, 2016; Doleac &
Hansen, 2016). Similarly, the use of drug testing prior to hiring may actually increase
young Black men’s’ chances of achieving employment; without evidence that Black men
are not using substances, employers may be less likely to hire them due to the belief that
they use drugs (Wozniak, 2014). Although these examples are not directly related to
healthcare, it is reasonable to speculate that the racial biases related to criminality present
in society at large impact healthcare and may contribute to treatment disparities.
Substance Use. Past or present substance use is another factor that likely impacts
pain treatment, and often with good reason (Centers for Disease Control, 2017;
Sinnenberg et al., 2017). Providers are increasingly aware of how prescription opioids
helped spur the current opioid crisis and that prescribed opioids can be easily misused or
diverted (Centers for Disease Control, 2017; Dowell, Haegerich & Chou, 2016).
Information about a patient’s past or present substance use (obtained through the health
history or urine drug testing) can provide clues about their risk for opioid misuse.
However, despite the recent publication of guidelines meant to assist providers in
decision-making surrounding chronic pain treatment, no “hard and fast” rules exist for
acute pain treatment, and provider discretion is required (Chou et al., 2016; Dowell,
Haegerich & Chou, 2016). Complicating acute pain treatment decision-making is the fact
that positive results on urine drug screens or self-reported substance use histories are not
necessarily indicative of increased risk for substance abuse. The CDC’s guidelines for
chronic pain prescribing warn against urine testing for substances that don’t directly
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influence treatment (marijuana, for example), as these positive results may leave
providers unsure of how to proceed (Dowell, Haegerich & Chou, 2016). However, many
institutions choose to retain marijuana testing on their testing panels, despite conflicting
opinions about how to deal with results (Washington State Agency Medical Directors’
Group, 2015). Additionally, a urine drug screen provides information about substances
that a patient used recently but does not provide a clear picture of a patient’s typical use
or how likely the patient is to engage in problematic substance use. How providers use
the results of urine drug screens, especially positive results of substances other than
opioids, is not well understood.
The undertreatment of pain may contribute to the use of prescription or nonprescription substances obtained illicitly (Alford et al. 2016; Lee, 2013). Lee’s
ethnographic study provides a case of a young Black man who sustained a gunshot
wound and struggled to receive adequate follow-up care after hospital discharge. His
unmanaged pain interfered with his ability to work and eventually led him to purchase
Percocet illicitly (Lee, 2013). Lee states that 8 of 9 participants in his parent study
reported acquiring Percocet illicitly in an attempt to manage undertreated injury-related
pain. People with a history of substance abuse may be especially vulnerable; those in
treatment for opioid use disorders report higher levels of pain than individuals without
opioid use disorders and pain is often a trigger for relapse into illicit substance use
(Alford, Compton & Samet, 2006; Eyler, 2013). People enrolled in medication-assisted
opioid treatment programs are at risk for undertreatment of acute and chronic pain, which
may lead them to self-treat pain with substances obtained illicitly (Alford et al. 2016;
Alford, Compton & Samet, 2006; Eyler, 2013). Although providers may limit opioid

11

prescriptions in a well-meaning attempt to decrease misuse, undertreated pain may also
lead individuals to participate in illicit activity to self-medicate. This behavior is
increasingly risky as many street drugs, including counterfeit opioid pills, are laced with
fentanyl (CDC, 2016).
Substance use is also importantly tied to the assumed criminality of Black people.
Although Black people are at no higher risk of misusing substances, they are incarcerated
for substance-related crimes at six to ten times the rate of White people (Alexander,
2010; Netherland & Hansen, 2017). Twenty-nine percent of people arrested and 33% of
people incarcerated for substance-related offenses are Black, while Black people make up
only 12.5% of Americans who use substances (NAACP, 2018). These statistics suggest
that substance abuse, although a rapidly growing problem among White citizens in the
US, is more likely to be treated as a criminal justice concern when Black people suffer
from it (Netherland & Hansen, 2017).
This dissertation is organized such that Chapter 1 provides the background,
specific aims and theoretical foundations of the dissertation study. Chapter 2 provides a
mixed-studies review of the literature focused on factors influencing receipt of pain
treatment in injured Black patients. Chapter 3 contains the manuscript that quantitatively
describes the factors that predict the receipt of discharge opioid prescriptions in a cohort
of seriously injured Black men. Chapter 4 contains the manuscript that qualitatively
explores the factors that providers take into consideration when prescribing pain
treatment during discharge planning in seriously injured patients.
While this dissertation study is focused on racial disparities in pain treatment (and
in Chapter 3, specifically about factors influencing pain treatment within a cohort of
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patients at risk of disparities in treatment due to race), in the qualitative study presented
in Chapter 4 I asked providers about their experiences planning discharge pain treatment
for all patients. I was interested in any factors that providers might identify as important
when planning discharge pain treatment and I imagined that a wide variety of factors,
including patient characteristics, might impact pain treatment. In addition, because
implicit bias is subconscious, providers are likely unaware that they harbor beliefs that
may lead to disparities in treatment and would deny them if asked. Providers who are
aware of their biases may be hesitant to share them. For this reason, I chose to ask about
their experiences with all patients requiring discharge pain treatment and allow providers
to share whatever factors or patient characteristics they believed to be relevant.
Strengths and Limitations
This multi-methods study is the first to explore how intentionality of injury may
impact pain treatment at hospital discharge. While a few valuable studies focus
qualitatively on the experiences of injured Black patients (Jacoby, 2015; Liebchutz et al.,
2010; Patton et al., 2016; Rich, 2009) and ED physicians’ decision-making related to
opioid treatment (Sinnenberg et al., 2017), no studies have explicitly studied the impact
of injury intent on receipt of discharge opioid prescriptions or qualitatively explored
providers’ considerations and experiences surrounding pain treatment for seriously
injured patients at hospital discharge.
All participants in this multi-methods study reside in the greater Philadelphia
metropolitan area, which may limit generalizability to other locations. Additionally, all
participants of the quantitative arm of this study (Chapter 3) are Black men. This
provides the unique opportunity to describe factors that influence receipt of pain
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treatment within a group of patients who are at risk of pain undertreatment due to race,
however, we were unable to compare factors that impact receipt of discharge opioid
prescriptions across races and genders. The participants in the qualitative arm of the study
(Chapter 4) were all providers at the same institution. Clinical decision-making is most
likely impacted by institutional norms and guidelines, especially if a provider was trained
at the institution. Findings from this study may not be generalizable to other institutions.
Significance
The purpose of this study was to add to the body of knowledge surrounding
disparities in pain treatment by describing the factors associated with discharge opioid
prescriptions in a cohort of injured Black men and exploring providers’ considerations
regarding discharge pain treatment. This research addressed intentionality of injury,
which has yet to be assessed as a possible factor influencing pain treatment. Intentional
injury, either by gunshot wound, stabbing or assault is a leading cause of morbidity and
mortality in young men, and young Black men are at especially high risk (Cook et al.,
2017). Taken together with substance use history, these factors may influence care
because of “assumed criminality” of certain patients due to patient characteristics that
may raise suspicion in providers. Although healthcare providers are responsible for
providing care that takes into consideration the safety of both their individual patients and
the greater community, they are not expected to function as law enforcement officers, and
a criminal background or suspected criminal background does not negate a patient’s right
to quality care. In addition, the assumed criminality of certain patients based on
characteristics such as race, gender, injury intent or substance use history (or a
combination of these characteristics) represents a bias not acceptable in healthcare.
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Evidence from other disciplines suggests that this bias exists at a societal level, and this
dissertation study seeks to begin the assessment of its influence on healthcare.

15

References
Agan, A., & Starr, S. (2016). Ban the box, criminal records, and statistical discrimination:
A field experiment. University of Michigan Law School, Law and Economics
Research Paper Series, 16.
Alexander, M. (2010). The New Jim Crow. New York: The New Press.
Alford, D., Compton, P., & Samet, J. (2006). Acute pain treatment for patients receiving
maintenance methadone or buprenorphine therapy. Annals of Internal
Medicine, 144(2), 127–134.
Alford, D. P., German, J. S., Samet, J. H., Cheng, D. M., Lloyd-Travaglini, C. A., &
Saitz, R. (2016). Primary care patients with drug use report chronic pain and selfmedicate with alcohol and other drugs. Journal of General Internal Medicine,
31(5), 486–491.
Anderson, K., Green, C. R., & Payne, R. (2009). Racial and ethnic disparities in pain:
Causes and consequences of unequal care. The Journal of Pain, 10(12), 1187–
1204.
Becker, W. C., Starrels, J. L., Heo, M., Li, X., Weiner, M. G., & Turner, B. J. (2011).
Racial differences in primary care opioid risk reduction strategies. Annals of
Family Medicine, 9(3), 219–225.
Becker, W. C., Sullivan, L. E., Tetrault, J. M., Desai, R. A., & Fiellin, D. A. (2008). Nonmedical use, abuse, and dependence on prescription opioids among US adults:
Psychiatric, medical, and substance use correlates. Drug and Alcohol
Dependence, 94, 38–47.
Caron, C. (2018, May 9). A Black Yale Student Was Napping, and a White Student
Called the Police. The New York Times. Retrieved
from https://www.nytimes.com/2018/05/09/nyregion/yale-black-student-nap.html
Centers for Disease Control. (2017a). Leading Causes of Death (LCOD) by Age Group,
Black Males-United States, 2014. Retrieved
from https://www.cdc.gov/healthequity/lcod/men/2014/black/index.htm
Centers for Disease Control. (2017b). Prescription Opioids. Retrieved
from https://www.cdc.gov/drugoverdose/opioids/prescribed.html
Chapman, C. R., & Vierck, C. (2017). The transition of acute postoperative pain to
chronic pain: An integrative overview of research on mechanisms. The Journal of
Pain, 18(4).

16

Chou, R., Gordon, D. B., de Leo-Casasola, O., Rosenberg, J. M., Bickler, S., Brennan, T.,
… Wu, C. L. (2016). Management of postoperative pain: A clinical practice
guideline from the American Pain Society, the American Society of Regional
Anesthesia and Pain Medicine, and the American Society of Anesthesiologists’
Committee on Regional Anesthesia, Executive Committee, and Administrative
Council. The Journal of Pain, 17(2), 131–157.
Cook, A., Osler, T., Hosmer, D., Glance, L., Rogers, F., Gross, B., … Malhotra, A.
(2017). Gunshot wounds resulting in hospitalization in the United States: 20042013. Injury, 48(3), 621–627.
Converse, L., Barrett, K., Rich, E., & Reschovsky, J. (2015). Methods of observing
variations in physicians’ decision: The opportunities of clinical vignettes. Journal
of General Internal Medicine, 30(3), 586–594.
Doleac, J., & Hansen, B. (2016). Does “ban the box” help or hurt low-skilled workers?
Statistical discrimination and employment outcomes when criminal histories are
hidden (No. 22469). National Bureau of Economic Research.
Dowell, D., Haegerich, T. M., & Chou, R. (2016). CDC Guideline for Prescribing
Opioids for Chronic Pain -- United States 2016 (MMWR Recommendations and
Reports No. 1) (pp. 1–49). Centers for Disease Control. Retrieved
from https://www.cdc.gov/mmwr/volumes/65/rr/rr6501e1.htm
Eyler, E. (2013). Chronic and acute pain and pain management for patients in methadone
maintenance treatment. The American Journal on Addictions, 22, 75–83.
Greenwald, A. G., McGhee, D. E., & Schwartz, J. L. K. (1998). Measuring individual
differences in implicit cognition: The implicit association test. Journal of
Personality and Social Psychology, 74(6), 1464-1480. doi:10.1037/00223514.74.6.1464
Haider, A. H., Sexton, J., Sriram, N., Cooper, L. A., Efron, D. T., & Swoboda, S. (2011).
Association of unconscious race and social class bias with vignette-based clinical
assessments by medical students. Journal of the American Medical
Association, 306(9), 942–951.
Haider, A., Schneider, E., Sriram, N., Dossick, D., Scott, V., Swoboda, S., … Cooper, L.
(2014). Unconscious race and class bias: It’s association with decision making by
trauma and acute care surgeons. Journal of Trauma and Acute Care
Surgery, 77(3), 409–416.
Hirsh, A. T., Hollingshead, N. A., Ashburn-Nardo, L., & Kronke, K. (2015). The
interaction of patient race, provider bias, and clinical ambiguity on pain
management decisions. The Journal of Pain, 16(6), 558–568.

17

Institute of Medicine. (2003). Unequal Treatment: Confronting Racial and Ethnic
Disparities in Healthcare. Washington, DC: Institute of Medicine.
Institute of Medicine. (2011). Relieving Pain in America: A Blueprint for Transforming
Prevention, Care, Education, and Research (full printed version). Washington,
DC: The National Academies Press.
International Association for the Study of Pain. (2017, December 14). IASP
Terminology. Retrieved from https://www.iasppain.org/Education/Content.aspx?ItemNumber=1698
Kahn, J. (2012). The troubling persistence of race in pharmacogenomics. Journal of Law,
Medicine & Ethics, 40(4), 873–885.
Kim, H. J., Yang, G. S., Greenspan, J. D., Downton, K. D., Griffith, K. A., Renn, C. L.,
… Dorsey, S. G. (2017). Racial and ethnic differences in experimental pain
sensitivity: systematic review and meta-analysis. Pain, 158(2), 194–211.
King, N. (2017, November 4). Why is the opioid epidemic overwhelmingly white? All
Things Considered. National Public Radio. Retrieved
from https://www.npr.org/2017/11/04/562137082/why-is-the-opioid-epidemicoverwhelmingly-white
Lee, J. (2013). The pill hustle: Risky pain management for a gunshot victim. Social
Science & Medicine, 99, 162–168.
Liebchutz, J., Schwartz, S., Hoyte, J., Conoscenti, L., Christian, A. B., Muhammad, L.,
… James, T. (2010). A chasm between injury and care: Experiences of Black
male victims of violence. Journal of Trauma, 69(6), 1372–1378.
Maina, I. W., Belton, T. D., Ginzberg, S., Singh, A., & Johnson, T. J. (2018). A decade of
studying implicit racial/ethnic bias in healthcare providers using the implicit
association test. Social Science and Medicine, 199, 219-229.
Martin, M. (2000). Ethnicity and analgesic practice: an editorial. Annals of Emergency
Medicine, 35(1), 77–79.
McCaffrey, M., & Pasero, C. (1999). Pain: Clinical Manual (2nd ed.). St. Louis, MO:
Mosby.
Meghani, S. H., Byun, E., & Gallagher, R. M. (2012). Time to take stock: a meta-analysis
and systematic review of analgesic treatment for pain in the United States. Pain
Medicine, 13(2), 150–174.
Muhammad, K. G. (2011). Where did all the White criminals go? Reconfiguring race and
crime on the road to mass incarceration. Souls, 13(1), 72–90.
18

NAACP. (2018). Criminal Justice Fact Sheet. Retrieved
from http://www.naacp.org/criminal-justice-fact-sheet/
National Institutes of Health. (2010). Pain Management. Bethesda, MD: National
Institutes of Health. Retrieved
from https://www.report.nih.gov/nihfactsheets/ViewFactSheet.aspx?csid=57
Neighbor, M. L., Honner, S., & Kohn, M. A. (2004). Factors affecting emergency
department opioid administration to severely injured patients. Academy of
Emergency Medicine, 11(12), 1290–1296.
Netherland, J., & Hansen, H. (2017). White opioids: Pharmaceutical race and the war on
drugs that wasn’t. Biosocieties, 12(2), 217–238.
Oliver, M. B. (2003). African American men as “criminal and dangerous”: Implications
of media portrayals of crime on the “criminalization” of African American
men. Journal of African American Studies, 7(2), 3–18.
Oliver, M. N., Wells, K. M., Joy-Gaba, J. A., Hawkins, C. B., & Nosek, B. A. (2014). Do
physicians’ implicit views of African Americans affect clinician decision
making? Journal of the American Board of Family Medicine, 27(2), 177–188.
Owusu-Bempah, A. (2017). Race and policing in historical context: Dehumanization and
the policing of Black people in the 21st century. Theoretical Criminology, 21(1),
23–34.
Patton, D., Sodhi, A., Affinati, S., Lee, J., & Crandall, M. (2016). Post-discharge needs
of victims of gun violence in Chicago: A qualitative study. Journal of
Interpersonal Violence, 34(1): 135-155.
https://doi.org/https://doi.org/10.1177/0886260516669545
Rich, J. (2009). Wrong place, wrong time: Trauma and violence in the lives of young
black men. Baltimore: Johns Hopkins University Press.
Rich, J. D., Wakeman, S. D., & Dickman, S. L. (2011). Medicine and the epidemic of
incarceration in the United States. New England Journal of Medicine, 364(22),
2081–2083.
Ringkamp, M., Raja, S., Campbell, J., & Meyer, R. (2013). Peripheral Mechanisms of
Cutaneous Nociception. In S. McMahon, M. Koltzenburg, I. Tracey, & D. Turk
(Eds.), Wall & Melzack’s Textbook of Pain(6th ed.). Philadelphia, PA: Elsevier
Saunders.
Roberts, D. (2012). Fatal Invention: How Science, Politics, and Big Business Re-create
Race in the Twenty-first Century. New York: The New Press.
19

Sabin, J. A., & Greenwald, A. G. (2012). The influence of implicit bias on treatment
recommendations for 4 common pediatric conditions: pain, urinary tract infection,
attention deficit hyperactivity disorder, and asthma. American Journal of Public
Health, 102(5), 988–995.
Sinnenberg, L. E., Wanner, K. J., Perrone, J., Barg, F. K., Rhodes, K. V., & Meisel, Z. F.
(2017). What factors affect physicians’ decisions to prescribe opioids in
emergency departments? Society for Medical Decision Marking, 2(1).
https://doi.org/https://doi.org/10.1177/2381468316681006
Spencer, M. R., Warner, M., Bastian, B., Trinidad, J. P., & Hedegard, H. (2019). Drug
overdose deaths involving fentanyl, 2011-2016 (National Vital Statistics Report
No. 3). Centers for Disease Control and Prevention.
Stevens, M. (2018, April 15). Starbucks C.E.O. Apologizes After Arrests of 2 Black
Men. The New York Times. Retrieved
from https://www.nytimes.com/2018/04/15/us/starbucks-philadelphia-black-menarrest.html?action=click&module=inline&pgtype=Article
Substance Abuse and Mental Health Services Administration. (2014). Results from the
2013 National Survey on Drug Use and Health: Summary of National Findings.
Rockville, MD: US Department of Health and Human Services.
Taylor, O. R. (2018, May 17). Even in Oakland, calling the cops on black people just
living their lives. The San Francisco Chronicle. Retrieved
from https://www.sfchronicle.com/news/article/Even-in-Oakland-calling-thecops-on-black-people-12920652.php
Volkow, N. D., & McLellan, T. (2016). Opioid abuse in chronic pain--misconceptions
and mitigation strategies. The New England Journal of Medicine, 374(13), 1253–
1263.
Washington State Agency Medical Directors’ Group. (2015). Interagency Guidelines on
Prescribing Opioids for Pain. Retrieved
from http://www.agencymeddirectors.wa.gov/Files/2015AMDGOpioidGuideline.
pdf
Witherspoon, D. J., Wooding, S., Rogers, A. R., Marchani, E. E., Watkins, W. S., Batzer,
M. A., & Jorde, L. B. (2007). Genetic similarities within and between human
populations. Genetics, 176(1), 351–359.
Wozniak, A. K. (2014). Discrimination and the effects of drug testing on Black
employment (No. 20095). National Bureau of Economic Research.

20

Yudell, M., Roberts, D., DeSalle, R., & Tishkoff, S. (2016). Taking race out of human
genetics. Science, 351(6273). https://doi.org/10.1126/science.aac495

21

CHAPTER 2
Factors Influencing Receipt of Pain Treatment by Injured Black Patients: A Mixed
Studies Review of the Literature
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Abstract
Aim: To explore the factors that influence provider treatment decision making and the
receipt of pain management by injured Black patients in the United States.
Design: We completed a systematic mixed studies review using a results-based
convergent synthesis design.
Data Sources: PubMed, SCOPUS, and CINAHL were searched for articles published
between 2007-2017 using the search terms “African American”, “Black American”,
“race”, “pain treatment”, “pain management”, and “analgesia”. Twenty studies were
included in this review.
Review Method: A search of databases and hand-searching identified peer-reviewed
published papers. The Mixed Method Appraisal Tool was used to appraise the studies.
Results: The results indicate that assumptions of criminality based on stereotyping and
bias, healthcare provider characteristics, and racial myths about pain sensitization all
impact provider treatment decision making and the receipt of pain treatment by injured
Black patients.
Conclusion: These results provide important areas for further study, including how
assumed criminality of certain patients can negatively impact care.
Impact: This review addresses racial disparities in pain management by focusing on the
factors that impact the receipt of pain treatment by injured Black patients. The findings
will have an impact on providers who prescribe pain treatment and on the patients they
treat. These findings suggest that assumed criminality of certain patients can negatively
impact care, which is a type of bias not frequently explored or discussed in health
disparities research. This review will help inform further research in healthcare disparities
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and prompt providers to examine their assumptions about the patients for whom they
care.
Keywords: African Americans; Black Americans; Pain Management; Pain; Stereotyping;
Bias; Decision Making; Nurse; Opioids; Injuries; Systematic Mixed-Studies Review
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Introduction
Countless studies have reported the existence of racial disparities in pain
management. Black patients are less likely than White patients to receive pain medication
for a wide range of painful conditions, despite reporting similar levels of pain (Bernstein,
et al., 2009; Meghani, Byun, and Gallagher, 2012). Two Institute of Medicine reports,
“Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care” (2003)
and “Relieving Pain in America” (2011), include analyses of the breadth and scope of
this issue. Since the publication of these reports and subsequent studies that describe pain
treatment disparities, focus has shifted to exploring underlying reasons for racial
disparities in pain management.
Decisions about pain management take place within a broader social context. In
recent years, the opioid crisis in the United States (US) has received significant attention
and providers have an increased awareness of the importance of prescribing practices that
reduce the risk of opioid diversion and misuse (Department of Health and Human
Services, 2017; Strayer, Motov & Nelson, 2017). Also receiving mainstream attention is
the disproportionate number of Black men who are involved in the US criminal justice
system via the “War on Drugs” (Alexander, 2010). Black people are incarcerated for
substance-related crimes in the US at six to ten times the rate of White people, despite
using substances at similar rates as White people (Alexander, 2010; Netherland &
Hansen, 2017). These statistics suggest that the “War on Drugs” and governmental
responses to the opioid crisis have impacted racial groups in the US in disparate and
harmful ways (Netherland & Hansen, 2017).
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The US is currently experiencing an “opioid crisis”, with as many as 130
individuals dying from overdose daily (Centers for Disease Control [CDC], 2017).
Although the disturbing trends of addiction and overdose death have prompted a
necessary reevaluation of pain management, pain is still a common problem that requires
attention. One third of Americans suffer with pain, and pain is the leading reason
individuals access healthcare (National Institutes of Health, 2010; Volkow & McLennan,
2016). Due to the easy accessibility to powerful opioids on streets across the US,
individuals may self-treat unmanaged pain (Alford et al., 2016; Lee, 2013).
Injury-related pain management is an important topic for exploration since one in
ten adults in the US seek care in an emergency department (ED) every year for physical
injury (CDC, 2017). Further, certain mechanisms of injury are disproportionally borne by
minority populations. Black men in the US are twice as likely as White men to be
hospitalized for gunshot injuries and experience a disproportionate amount of non-fatal
violence (CDC, 2017; Moore et al., 2013). In the wake of the opioid crisis, the Centers
for Disease Control (CDC) released guidelines for the treatment of chronic pain (Chou et
al., 2016; Dowell, Haegerich & Chou, 2016). However, no guidelines currently exist for
the treatment of acute pain, thus requiring clinical discretion. This lack of guidance has
the potential to worsen pain treatment disparities.
Racial and ethnic disparities in healthcare is not a uniquely American problem.
Disparate access to quality healthcare and racism in healthcare remain serious issues in
South Africa, the United Kingdom, Canada, Brazil, Israel and Australia, among other
nations (Ahmed et al., 2016; Bastos, Harnois and Paradies, 2018; Burgard & Treiman,
2006; Chauhan, 2018; Saabneh, 2016; Salway et al., 2016). The unique racial and
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colonial histories of different countries influence the racial disparities that persist today,
but the experiences of marginalized groups in one geographical area may mirror the
experiences of populations in other parts of the world. Healthcare providers, policy
makers, and patients across the globe can benefit from an analysis of the factors
influencing the treatment of pain, which is a relevant concern worldwide.
Background
Racial disparities in pain treatment
Race is a sociopolitical construct and although greater genetic differences are
found within racial groups than between them, racial disparities and racism in the
workforce, education, and healthcare illustrate that the social construction of race has a
major impact on society (Roberts, 2012; Zuberi, 2003). Racial disparities in pain
management is one such example. Todd et al.’s (1993) seminal study of racial and ethnic
pain treatment disparities found that Latino/a patients were less likely to receive analgesia
for long-bone fracture than White patients. Nearly a decade later, a similar study found
that Black patients with acute pain from long-bone fractures were 66% more likely than
White patients with long-bone fractures to receive no analgesia in the ED, despite similar
expressed levels of pain (Todd et al., 2000).
A meta-analysis of disparities in both chronic and acute pain treatment found that
when analyzing all pain/condition types, Black patients were 29% less likely to receive
opioid analgesia than White patients (Meghani, Byun, & Gallagher, 2012). In cases of
acute pain due to trauma or surgery, Black patients were 14% less likely than White
patients to receive opioid analgesia. The difference was starker for pain caused by nontraumatic conditions (i.e., back pain, headaches, or stomach-ache) for which Black

27

patients were 34% less likely to receive opioid analgesia. Black patients are also less
likely than White patients to receive pain treatment during EMS transport for injuries due
to blunt trauma and falls as well as for treatment of joint dislocations in the ED (Infinger
& Studnek, 2014; Tsai et al., 2012; Young et al., 2013). Although socioeconomic status
(SES) may influence receipt of pain treatment, a national study examining receipt of
opioids for moderate to severe pain across racial and SES groups found that White
patients and patients of higher SES were more likely to receive opioids for pain than
Black or poor patients, and Black patients were less likely to receive opioids than White
patients across all SES levels (Joynt et al., 2013). This disparity extends to waiting time;
Black patients also experience longer ED wait times for treatment of painful conditions
than White patients (Shah et al., 2015; Tsai et al., 2012; Wheeler et al., 2010).
Disparity in pain treatment varies across different types of injury. While some
studies report no statistically significant racial difference in receipt of analgesia (opioid or
non-opioid) for patients with migraines or long-bone fracture, Black patients with back
pain are less likely than White patients to receive opioids (Dickason et al., 2015). It is
possible that the subjective nature of back pain may be partially responsible for this
difference, as compared to an injury like long-bone fracture which is associated with
more objective evidence of pain.
Racism in healthcare
Two discrete types of racism have been elucidated in disparities research: explicit
and implicit. Explicit bias refers to an individual’s negative beliefs about a group of
people based on race or socioeconomic class which are acknowledged by the individual,
whereas implicit bias describes attitudes which are unacknowledged, unexplored, and
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subconscious (Dovidio, Kawakami & Gaertner, 2002). Either type of bias may influence
behavior and some studies suggest that “aversive racism,” which refers to a situation of
low-level explicit but high-level implicit bias, may be especially harmful in patientprovider interactions (Penner et al., 2010). Implicit bias is related to mistrust, perceived
discrimination, and subpar communication in patient-provider relationships (Maina et al.,
2018). Although many studies of implicit and explicit bias have failed to show a
connection between the presence of bias and healthcare decision making (Dehon et al.,
2017), most of these studies employed vignettes and simulated patient encounters, which
may not effectively mirror real-life scenarios (Converse, Barrett, Rich & Reschovsky,
2015). It is unclear how racial bias, whether explicit or implicit, may impact provider
pain treatment decision-making.

The Review
Aim
The aim of this systematic mixed studies review explore the factors that influence
provider pain treatment decision-making and the receipt of pain treatment in injured
Black patients in the US. This review aimed to answer the following question: What
factors influence the receipt of pain treatment by injured Black individuals in the US?
Design
We completed a systematic mixed studies review (Pluye & Hong, 2014) using a
results-based convergent synthesis design (Hong, Plyue, Bujold & Wassef, 2017). This
design involves analyzing and synthesizing quantitative and qualitative data separately
and combining findings in a third synthesis. We chose this design because it allowed us
to integrate a diverse group of studies.

29

Search methods
Scopus, PubMed, and CINAHL were searched using the search terms “African
American”, “Black American”, “race”, “pain management”, “pain treatment” and
“analgesia.” Included studies were peer reviewed, quantitative or qualitative data-based
studies that focused on factors that influence provider pain treatment decision-making
and the receipt of pain treatment by Black patients aged 18-65 years with acute or chronic
injury-related musculoskeletal pain. Excluded were studies that focused exclusively on
the epidemiology of pain treatment disparities, as well as studies focused on conditions
other than acute or chronic musculoskeletal injury-related pain, such as pain related to
obstetrics, sickle-cell anemia, or cancer. Studies focused on pediatric or geriatric patients
were also excluded, due to the oftentimes complex nature of treating pain in these
populations. Included studies took place in the US and were published in English
between 2007-2017.
Search Outcome
The SCOPUS search resulted in 448 articles, the CINAHL search yielded 98
articles, and a search in PubMed yielded 206 articles. We extracted an additional 5
relevant articles from reference lists. Duplicates (n=248) were removed, and the titles and
abstracts of these 509 remaining articles were manually reviewed for relevance. A total of
20 original research studies were included in this review (See Figure 2.1). Reference lists
were evaluated by two independent raters, trained by a master coder. All articles included
in the final sample were agreed upon by three individuals.
Quality Appraisal
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The Table of Included Studies (see Table 2.1) contains concise information about
each study (see the online version for additional study details). We used the Mixed
Methods Appraisal Tool (MMAT) to appraise the studies (Hong et al., 2018; Pluye et al,
2011). The latest version of the MMAT encourages a descriptive quality appraisal rather
than a numerical score. The product of this appraisal can be found in Tables 2.2 and 2.3.
Data Abstraction & Synthesis
We extracted numerical data from quantitative studies and synthesized these data
narratively. We performed qualitative thematic synthesis to abstract and synthesize data
from qualitative studies (Hong, Plyue, Bujold & Wassef, 2017; Thomas & Harden,
2008). To form themes, studies were read in their entirety and findings from all included
studies were coded (Hong, Pluye, Bujold, Wassef, 2017). Codes were then grouped
together to develop themes (Pluye & Hong, 2013; Thomas & Harden, 2008). We then
performed a third synthesis to compare and combine quantitative and qualitative findings
and derive additional themes from the combination of these findings.
Results
As prescribed by results-based convergent synthesis design, quantitative and
qualitative data were analyzed and presented separately (Hong, Plyue, Bujold & Wassef,
2017). The results of the two syntheses are then combined in a third synthesis, and an
additional theme was derived by the combination of this data.
Synthesis of Quantitative Studies
Provider concern about risk of substance misuse. Providers may be more likely
to assume that Black patients are at risk for substance abuse than White patients, and this
may impact their care plans. A study by Becker et al. (2011) suggests that providers
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treating chronic pain may assume that Black patients are at higher risk of prescription
opioid misuse, as evidenced by higher rates of implementing risk-reduction techniques
with Black patients. This retrospective cohort study assessing the use of opioid riskreduction strategies (urine drug testing, required regular provider visits, and limited early
refills) with patients at eight primary care offices found that Black patients were more
likely to receive the risk-reduction strategies than White patients. After adjusting for
substance/tobacco use disorder diagnoses, Black patients were still more likely than
White patients to have regular provider visits (OR=1.51, 95% CI 1.06-2.14) and restricted
early refills (OR=1.55, 95% CI 1.03-2.32) (Becker et al., 2011). An additional
retrospective cohort study focused on opioid risk reduction strategies at the Pittsburgh
Veteran’s Affairs Healthcare System found that Black patients had more urine drug tests
performed than White patients (β=2.27, 95% CI 0.66-3.89, p=0.04). Black patients were
also more likely to have been referred to an addition specialist (OR=2.31, 95% CI 1.373.91), and less likely to have been referred to a pain specialist (OR=0.62, 95% CI 0.430.90) than White patients (Hausmann et al., 2013).
A study using clinical vignettes found that primary care physicians were more
likely to associate “challenging” verbal behavior (patient aggressively demanding opioid
medications for pain) with higher risk for substance abuse and non-compliance
(F(1,348)=4.11, p=0.04). However, this did not significantly impact prescribing;
challenging behavior did not significantly alter treatment decisions for White or Black
patients (Burgess, et al., 2008).
Healthcare provider characteristics. Characteristics of healthcare providers,
such as race, gender, experience, and empathy level may influence their pain treatment
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decision making. A study of physicians and dentists employed virtual human (VH)
technology (computer generated patients) and vignettes (written clinical scenarios) to
assess the impact of provider age, years of experience, race, and gender on pain
management decisions (Bartley et al., 2015). No significant differences were seen in pain
assessment by provider race, but female providers were more likely to “prescribe” nonopioid pain treatments to Black VH patients than White VH patients (F=5.22, p=0.02,
ŋp2=0.03), and providers with fewer years of experience were less likely to prescribe
opioids to Black VH patients (F=3.90, p=0.05, ŋp2=0.03). Nurses were more likely than
physicians to state that they would administer opioids to patients with chronic low back
pain in a VH study (F=14.08, p<0.001, ŋp2=0.07). (Wandner et al., 2014). Furthermore,
both nurses and physicians were more likely to prescribe opioids for Black and male VHs
than White or female VHs (Wandner et al., 2014).
A real-life study conducted at multiple EDs measured treatment of moderate to
severe pain by a racially diverse group of physicians. Although there was no significant
difference in the amount of analgesia prescribed by White vs. non-White physicians,
patients who saw non-White physicians were more likely to report a reduction in pain
intensity (61% reported reduction vs. 47%, p=.008) (Heins et al., 2010). Race
concordance between physician and patient did not have any effect on pain reduction.
The findings of these studies suggest that the race and gender of an individual assessing
and treating pain may influence the way that individual responds to the person
experiencing pain.
Provider empathy may play an important role in pain management decisions.
Drwecki and colleagues (2011) conducted a VH randomized controlled trial of nurses in

33

which half were assigned to receive a “perspective-taking intervention.” This intervention
involved instructing participants to reflect on the pain that their virtual patients were
experiencing both before and after watching the patient videos and before making
treatment decisions, with the goal of increasing empathy. Nurses in the control group
exhibited a racial treatment bias (more likely to state that they would order pain
treatments for White patients than Black patients), while nurses in the intervention group
did not; the intervention yielded a 65% decrease in pain treatment bias. Treatment bias
for White nurses decreased 55% with the perspective-taking intervention.
A provider’s mental state may also have an impact on pain treatment decision
making. Differing levels of cognitive load, which is described as “the amount of mental
activity imposed on working memory,” can translate into disparate pain treatment
decisions (Burgess et al., 2014, p. 965). Male physicians with high cognitive load (e.g.,
complete multiple tasks at once under time pressure) were less likely to prescribe opioids
to Black simulated patients than White simulated patients (30% vs 12.5%, p=0.034)
(Burgess et al., 2014). The opposite was true under conditions of low cognitive load (e.g.,
ample time to make treatment decisions and able to focus on one task at a time).
Myths about pain sensitization. Despite evidence that race does not impact the
way that patients rate injury pain (Bernstein, et al., 2009), some providers and laypeople
believe that Black patients are less sensitive to pain than White patients. A study focused
on “false beliefs” about racial biologic differences found that both medical students
(F=9.56, p=0.002 ŋp2=0.02) and laypeople (F=5.50, p=0.021, ŋp2=0.06) harbored false
beliefs about Black people, including a belief that Black people were less sensitive to
pain (Hoffman et al., 2016). Another study found that nurses and nursing students rated
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the amount of pain that a Black person might feel if they experienced a certain injury as
lower than the pain that a White person might feel from the same injury (F=4.90, p=0.03,
d=0.72) (Trawalter et al., 2012).
A descriptive study focused on chronic pain at 12 medical centers found that
Black patients are twice as likely as White patients to have their pain underestimated by
physicians (OR=1.92, 95% CI 1.31-2.81, p<.05) (Staton, et al., 2007). Additionally, a
chart review of VA health records found that Black patients are less likely to be screened
for pain than White patients despite the VA’s pain screening requirement, which may in
part be due to provider beliefs about how individuals of different races experience pain
(OR=0.86, p<0.001) (Burgess, et al, 2013). If providers believe that Black patients are
less sensitive to pain, it is possible that they may prescribe less pain treatment to Black
patients, erroneously assuming that they are in less need of pain management.
Synthesis of Quantitative Studies
Stigmatization of intentionally injured patients. Providers may be suspicious of
patients who are injured violently, assuming that they had been involved in criminal
activity. Rich’s (2009) qualitative study of intentionally injured Black men illustrates that
healthcare providers are likely to ignore the dangerous realities of life in some
neighborhoods and assume that young Black men “did something” to warrant their
injuries. It is possible that suspicion of criminal involvement may lead to provider
concern about opioid misuse as well as blunted provider empathy for patients. Patton et
al. (2016) conducted in-depth interviews with 10 Black patients who had experienced
gunshot wounds. Participants reported “feeling stigmatized” by healthcare providers due
to the mechanism of their injuries and some reported suboptimal care (neglect by hospital

35

staff and a lack of communication about treatment). Participants reported being
discharged before they felt they were ready to leave the hospital and difficulty accessing
ongoing treatment after discharge. Implicit bias about violently injured people may lead
to suboptimal care: “the stream of wounded young people may perpetuate stereotypes
about gunshot victims as gang-members, drug dealers, or individuals whose lifestyle
choices caused their injuries” (Patton et al., 2016, p. 17).
In describing the case of one participant from an ethnographic study of violently
injured Black men, Lee (2013) explored the experiences of a young man who sustained a
gunshot wound during an interpersonal confrontation that did not involve criminal
activity on the part of the participant. This man lacked sufficient follow up care postdischarge and stated that he was refused adequate pain treatment by his provider. Due to
his unmanaged pain he self-medicated with prescription medications he bought illicitly,
which led to a drastic worsening of his health status and engagement in criminal activity
(Lee, 2013).
Mistrust & it’s impact on care. Participants in a grounded theory study of 16
urban Black men with gun and knife injuries described mistrust of the medical
establishment, leading to lack of engagement in care (Liebschutz et al., 2010). The
experience of being questioned by police while receiving care, a common phenomenon in
cases of violent injury, added to this mistrust. A qualitative study of emergency medicine
(EM) physicians, “trustworthiness” of a patient was identified as an important factor in
the pain treatment decision making process (Sinnenberg, et al. 2017). Physicians reported
that they were less likely to prescribe opioids to patients that they believed to be engaging
in “drug-seeking” behavior. The physician participants stated that factors such as a
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patient being from out of town or a patient coming to the ED multiple times for painful
conditions raised their suspicions of drug-seeking. Additionally, the ability to relate to the
patient and his or her pain was a factor in decision-making; one physician reported that
he knew how painful a certain condition was because of his own personal experience
with it, which made him aware of the need for pain treatment. These results suggest that
some providers are more likely to prescribe opioids to patients they perceive as
trustworthy and whose conditions they can relate to.
Synthesis of findings from quantitative and qualitative studies
Combination of findings derived from the syntheses described above resulted in
an additional theme.
Assumed criminality. The results of the qualitative synthesis (stigmatization of
intentionally injured patients and mutual mistrust), when considered in tandem with
quantitative results suggesting increased provider suspicion of substance abuse risk in
Black patients versus White patients, highlight the possibility of provider bias regarding
the “assumed criminality” of Black patients. Assumed criminality refers to the belief that
someone is engaged in crime despite a lack of firm evidence of criminal behavior. This
bias could cause providers to believe that a Black patient may be more likely to misuse or
divert prescribed medications or could cause providers to display a lack of empathy
towards Black patients, especially intentionally injured Black patients. Liebschutz and
colleagues’ findings suggest that this perceived bias can lead patients to mistrust the
medical establishment limit patient engagement after discharge (2011). EM physicians
voiced that trustworthiness and the ability to relate to patients and their experiences
influence their pain management plans (Sinnenberg, et al. 2017).
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The final results of this review were the themes racial myths about pain
sensitization, healthcare provider characteristics (both derived from synthesis of
quantitative studies), and assumed criminality (derived from combination of findings
from quantitative and qualitative studies). These results were integrated into a theoretical
model (Figure 2) that describes post-injury pain treatment provider decision-making in
hospital or outpatient clinic settings. This model addresses the impacts of injury
characteristics, patient characteristics, setting characteristics, provider characteristics,
provider assumptions, and clinical judgment on discharge pain treatment. Assumptions
about a patient’s need for pain treatment may be impacted by racial myths about pain
sensitization, and assumed criminality may influence a provider’s concern about a
patient’s risk for substance misuse or diversion. Both of these assumptions are based
partially on healthcare provider characteristics, which include a provider’s experience,
education, and beliefs.
Discussion
This review illuminates the complexity of factors underpinning racial disparities
in pain treatment. While much of the epidemiological literature points to the clear
existence of pain treatment disparities due to race, some studies have shown that this
disparity is more pronounced in painful conditions that present with subjective
complaints, like backache (Dickason et al., 2015; Meghani, Byun & Gallagher, 2012).
Provider-patient trust plays an important role, with providers being more likely to trust
the need for pain treatment if signs of pain are visible to the provider. In cases where
reports of pain are subjective, providers may be more likely to subconsciously rely on
other methods of determining “trustworthiness,” and race may influence this decision.
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Providers are more likely to have negative feelings towards Black and poor
patients; providers rate Black patients as at higher risk for substance abuse, lack of
compliance with medical advice, and as less intelligent than White patients (van Ryn &
Burke, 2000). Providers are also less likely to trust marginalized (homeless, poor, HIVpositive) Black patients than marginalized White patients (Moskowitz et al., 2011). A
vignette study found that rates of opioid “prescribing” by physicians increased slightly
when the participants were provided information about social characteristics that may be
associated with perceived trustworthiness, such as higher income and employment
(Tamayo-Sarver et al., 2003). “Cognitive load” may also affect providers’ treatment
decisions; when providers are overwhelmed with time constraints and ambiguous
situations (like subjectively painful conditions), they are more likely to rely on racial,
ethnic, and SES stereotypes (Burgess, 2010). This is relevant to acute injury
management, as trauma centers are often busy places where providers are working with
time constraints and high complexity situations. Providers working in these centers are
more likely to have higher “cognitive loads” than providers in less stressful clinical
settings, and therefore may be more likely to rely on stereotypes to guide decisionmaking.
Although there is a lack of research that examines how intentionality of injury
may impact pain treatment decisions, it is relevant to consider. Black men are
disproportionately affected by violence and are more likely than White men to be
hospitalized for violent injury. Providers may be more likely to distrust violently injured
people because they are less “relatable” and providers may assume that they are involved
in crime (Rich, 2009). These suspicions may function to both cause providers to worry
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about misuse of pain medications and to reduce empathy levels. As asked by Martin
(2000, p. 78) “…does the patient who presents with a long bone fracture caused by a ski
injury receive different care than the patient who is brought to the ED with a long bone
injury caused by police under arrest secondary to an altercation?” This review highlights
the need for additional research exploring the impact of intentionality and how it may
influence provider attitudes towards patients.
Black individuals, particularly Black men, are more likely than other demographic
groups to be “assumed criminal” by society at large, regardless of actual criminal
background (Oliver, 2003). A recent example of the conflation of Blackness with
criminality is an unintended consequence of the well-intentioned “Ban the Box” policy,
which forbids employers from asking about the criminal records of applicants in the early
stages of job applications. Unable to check applicants’ criminal backgrounds, employers
are less likely to even begin the interview process with certain individuals (low-skilled
young Black men), presumably because they believe that that these individuals are likely
to have criminal backgrounds. This has resulted in a disparity in the rates of “call-backs”
between White and Black applicants (White applicants are 45% more likely to be called
back for an interview) and a 5.1% decrease in the chances of job attainment for lowskilled young Black men (Agan & Starr, 2016; Doleac & Hansen, 2016). Similarly, an
increase in the use of drug testing prior to hiring may actually be associated with higher
rates of employment for Black individuals, as without the results of a drug test employers
may assume that a Black applicant is likely to abuse substances. With objective evidence
challenging those assumptions, employers may be more willing to hire Black applicants
(Wozniak, 2014).
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Although these examples are not specifically related to healthcare, it is reasonable
to assume that anyone who lives in a society afflicted by racism is affected by it to a
certain degree. As stated by Burgess et al., “physicians' fears of potential diversion of
narcotics, in which patients are characterized as potential criminals, may help trigger the
stereotype of “black drug dealer” or “black criminal” in encounters with African
American patients, because those stereotypes are prevalent in the larger society” (2008, p.
1853). Future research focused on the assumed criminality of Black men in healthcare
spaces is an important step in the effort to address pain treatment disparities.
Myths about pain sensitization based on race may be widespread and not limited
to healthcare providers. Studies by Wandner et al. (2012) and Hollingshead et al. (2016)
suggest that undergraduate students believe that Black people feel less pain than White
people and therefore require less pain treatment for painful conditions. While
undergraduate students are not healthcare providers, it is possible that they will become
providers in the future and carry those beliefs about racially-based pain sensitization into
their practice. These findings may additionally represent an acceptance of a “race-based
pain sensitization myth” in greater society which also impacts healthcare. Providers who
consciously or subconsciously harbor these beliefs may be more likely to assume that
Black patients can “tough it out” and treat Black patients’ pain less aggressively. This
belief, along with the assumed criminality of Black men, suggests a dehumanization of
Black patients that can lead to healthcare professionals believing (consciously or
subconsciously) that Black patients need or deserve less care than White patients.
Contemplating the studies presented in this review, it is important to consider that
there is a lack of randomized controlled trials and the scientific rigor in this field is still
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developing. In addition, the utility of virtual human technology or vignettes as substitutes
for real-life clinical situations is questionable. While simulated strategies provide
opportunity to study phenomena that may be otherwise difficult to assess, they may not
mirror human interactions sufficiently to render generalizable results. It is possible that
this is one of the reasons why the findings of studies exploring what providers state they
would do in various patient scenarios (ie., prescribe or withhold pain treatment) do not
align with the findings of descriptive studies which suggest ongoing treatment disparities.
Conclusion
Racial disparities in pain treatment are clearly unjust and can understandably sow
mistrust in healthcare providers among individuals in communities harmed by these
disparities, which can lead to an avoidance of care. The results of this review provide
important areas for further study, including how intentionality of injury (intentional
versus unintentional) may impact patient “trustworthiness” and the receipt of pain
treatment. Due to the disproportionate burden of violent injury suffered by Black men,
this area of study may be especially important in the effort to understand and mitigate
these pain treatment disparities. The “assumed criminality” of certain populations,
particularly people of color, can negatively impact the way people are treated by law
enforcement, potential employers, healthcare providers, and the general public. How the
“assumed criminality” of certain patients by providers may impact the quality of care that
these patients receive has not been thoroughly explored, but is vital to address healthcare
disparities.
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Tables
Table 2.1: Table of Evidence
Author

Objective

Design

Sample

Setting

Findings

Bartley
et al. 2015

Assess whether
provider
characteristics (age,
race, gender) impact
pain treatment
decisions for injuryrelated back pain or
dental pain

Descriptive
cross-sectional

n=154; dentists
and physicians
(69% White, 31%
non-White)

Video
vignette and
virtual
human lab

Significant differences in
pain rating and treatment
decisions related to
provider and patient race,
gender, and age, and
provider years of
experience
Female providers more
likely to prescribe nonopioids to Black patients
(F=5.22, p=0.02,
ŋp2=0.03)
Providers with fewer
years of experience less
likely to prescribe
opioids to Black patients
(F=3.90, p=0.05,
ŋp2=0.03).

2

Becker
et al. 2011

Compare primary care
physicians use of
opioid-risk reduction
strategies for Black
vs. White patients
with chronic
musculoskeletal pain

Retrospective
cohort, chart
review

n=1612; pt’s aged
18+, ICD-9 dx of
chronic
musculoskeletal
pain, were rx'd
chronic opioid
treatment (62%
Black patients,
38% White)

8 primary
care
practices in
PA

Black patients
significantly more likely
(p<.01) to have regular
office visits (OR=1.51,
95% CI 1.06-2.14) and
restricted early refills
(OR=1.55, 95% CI 1.032.32) than White patients

50

1

Strengths &
Limitations
S: Larger number of nonWhite participants than
similar studies
L: Virtual humans &
vignettes may not reflect
real life scenarios; did
not control for provider
pain management
experience; lumping of
non-White race in
analysis

S: Multiple primary care
practices
L: Only one city, low
utilization of urine drug
testing overall limited
power to detect
difference

Design

Sample

Setting

Findings

Strengths &
Limitations
S: Patients excluded from
parent study if
intoxicated
L: Did not measure
patients’ perceived
ability to tolerate pain

Objective

3

Bernstein et al.
2009

Assess whether
ethnicity or race
impacts self-rating of
pain on 0-10 scale in
patients with long
bone fracture

Retrospective
chart review

n=838; patients
aged 18-55
presenting to ED
with long bone
fracture (56%
female
participants, 49%
Latino, 29%
Black, 22%
White)

Two urban
EDs

No significant difference
in baseline pain ratings
related to ethnicity or
race

4

Burgess
et al. 2008

Assess whether
patient race and
behavior (verbal and
non-verbal) impacts
provider pain
treatment decision
making in cases of
chronic low-back pain
in men
(challenging behavior
defined as demanding
of opioids, asks for
opioid by name,
aggressive about need
for pain treatment)

Descriptive
cross-sectional

n=382; primary
care physicians,
national sample
(70% male,
41.6% White
participants)

Paper-based
vignette,
completed in
place of
participants
choosing

No significant difference
in opioid prescribing for
challenging vs nonchallenging behavior in
White or Black patients

S: Large national sample
of physicians; studied
patient behavior as well
as race
L: VH and vignettes; low
response rate of
physicians (40%)

5

Burgess
et al. 2013

Assess whether White
patients are more
likely to receive
screening for pain
than Black patients

Retrospective
cohort, chart
review

n=245,504; VA
patients (10%
Black patients,
90% White
patients)

National VA
records

Black patients less likely
to have documented pain
screening than White
patients (OR=0.86,
p<0.0001)

S: Very large national
sample
L: Pain may have been
screened but not
documented in chart

51

Author

Author

Objective

Design

Sample

Setting

Findings

Strengths &
Limitations
L: VH and vignettes;
difficult to control if
participants are following
protocol; possible selfselection sampling bias

Burgess
et al. 2014

Assess whether
cognitive load impacts
pain treatment
decisions of
physicians seeing
patients for chronic
low-back pain

Web-based
randomized
trial

n=198; VA
physicians (49%
female, 64%
White
participants)

Web-based

Male physicians more
likely to prescribe
opioids to White patients
vs. Black patients under
high cognitive load (30%
vs 12.5%, p=0.034)

7

Drwecki et al.
2011

Assess whether
perspective-taking
empathy intervention
can have impact on
racial pain treatment
disparities

RCT

n=38; registered
nurses (80%
female, 77%
White
participants)

University of
Wisconsin
VH and
vignette lab

Nurses in the
perspective-taking
intervention group did
not exhibit a racial
treatment bias
(t(18)=1.75, Cohens
d=0.26, p=.10), while
nurses in control group
did (t(20)=2.81, Cohens
d=0.77, p=.01).
Intervention yielded 65%
decrease in racial
treatment bias.

L: Small sample; single
site; possible sampling
bias; VH and vignettes

8

Hausmann et
al. 2013

Compare opioid
monitoring of Black
and White patients at
a VA outpatient
system

Retrospective
cohort, chart
review

n=1899, patients
aged 18+ (86%
White patients,
13% Black
patients)

Pittsburgh
VA system

Black patients had higher
number of urine drug
screens (unadjusted beta
coefficient=2.27, 95% CI
0.66-3.89, p=0.4), were
more likely to be referred
to substance abuse tx
(OR=2.31, 95% CI 1.373.91, p<.001), and were
less likely to be referred
to pain specialist
(OR=0.62, 95% CI 0.430.90, p=.01)

S: Able to control for
substance abuse and
mental illness dx
L: 90% of patients male,
small subsample of Black
patients, no data about
patient behaviors r/t
possible opioid misuse

52

6

Author

Objective

Design

Sample

Setting

Findings

Heins et al.
2010

Explore the
relationship between
race of patients, race
of providers, and pain
treatment
effectiveness in the
ED

Descriptive
cross-sectional

n=776; patients
aged 18+ with
moderate-severe
pain (44% White,
26% Black, 26%
Latino), (85% of
patients saw a
White provider)

20 EDs in
the US

No difference in opioid
or non-opioid analgesia
prescribing across
provider races, but
patients seen by nonWhite providers more
likely than those seen by
White providers to report
meaningful reduction in
pain (2 points or greater
on pain scale) (61%
report reduction vs. 47%,
p=.008). Patient race was
not significant.

10

Hirsh
et al. 2015

Assess how patient
race, provider racial
bias, and clinical
ambiguity impact pain
treatment decisions in
virtual humans with
fracture (low
ambiguity condition)
or back pain (high
ambiguity condition)

Descriptive
cross-sectional

n=129; medical
residents, national
sample (54%
male, 56% White
participants, 2%
Black
participants)

Virtual
human and
vignettes
were emailed
to
participants
to complete
on personal
computers

11

Hoffman
et al. 2016

Assess the beliefs of
laypeople and medical
students regarding
biological differences
based on race and if
these beliefs impact
pain ratings

Descriptive
cross-sectional

n=92 laypeople &
222 medical
students from
University of
Virginia (100%
White
participants)

Vignettes
and survey
completed at
University of
Virginia

Black patients were
considered to be
experiencing higher
levels of pain than White
patients in high
ambiguity situations,
while White patients
were considered to be in
more pain than Black
patients in low ambiguity
situations.
Participants who
endorsed false beliefs
about racial biological
differences were more
likely to underrate the
pain of Black individuals
relative to White
participants (Medical
students: F=9.56,
p=0.002 ŋp2=0.02;
Laypeople: F=5.50,
p=0.021, ŋp2=0.06)

S: National sample
L: Only medical
residents, virtual humans
& vignettes

53

9

Strengths &
Limitations
S: Multi-center and
multi-country, focused
on effectiveness of tx
L: Small subsample of
non-White providers, no
data about analgesia
administration pre-ED

L: No practicing
clinicians included in
sample; single-site;
vignettes; only White
participants

Author

Objective

Design

Sample

Setting

Findings

Hollingshead
et al. 2015

Assess the impact of
patient race and
gender on provider
pain treatment
decision making in
patients with chronic
low back pain &
provider awareness of
the impact of patient
characteristics on pain
treatment decisions

Mixed methods:
descriptive
cross-sectional
& qualitative
interviews

n=20; medical
trainees (10
medical students,
10 residents, 65%
female, 70%
White
participants, 5%
Black
participants)

Survey
completed on
home
computers or
in computer
lab at Indiana
University;
interviews
completed in
person on
campus

Group level analysis
found no significant
difference in pain
treatment decisions by
gender or race of patient.
Participants were more
likely to recommend
anti-depressant treatment
to White patients than
Black patients
(t(19)=2.159, p<0.05,
dz=0.48)
In qualitative portion,
participants stated that
SES was more important
than race and none of the
participants reported
using race as a
consideration when
making pain treatment
decisions

13

Lee, 2013

Examine how
individuals injured by
gun violence cope
with pain when they
don’t have access to
healthcare

Ethnography

n=1; participant
from larger study

PA

Participant was not
involved in crime at the
time of his injury, he
experienced difficulty
accessing care to treat his
debilitating pain, his pain
interfered with his ability
to work and he turned to
illicit activities out of
necessity

54

12

Strengths &
Limitations
S: Mixed methods
L: Small sample; Small
number of non-White
participants

S: Researcher built
trusting relationship with
participant, was able to
follow participant to
myriad places
L: Sample of one

Author

Objective

Design

Sample

Setting

Findings

Strengths &
Limitations
S: Interviewers received
training before interviews
began
L: Possible bias of
interviewers, possible
selection bias of
participants

Liebschutz
et al. 2010

Describe the
healthcare
experiences of Black
men who are injured
violently

Grounded
Theory, semistructured
interviews

n=16; Black men
aged 18-38 who
had received
emergency
medical care for a
gunshot or knife
injury

Boston

Participants reported lack
of trust in relationship
with healthcare
providers, perceived
disrespect and/or
indifference from
healthcare providers,
barriers accessing care
after their injury

15

Patton
et al. 2016

Explore the needs of
Black patients who
are injured violently

Grounded
theory, semistructured
interviews

n=10; Black
patients aged 1840 with history of
gunshot wound
requiring
hospitalization (1
female
participant, 9
male participants)

Level 1
trauma
center at
Midwestern
hospital

Participants reported
perceived stigmatization
by healthcare related to
mechanism of injury,
belief that mechanism
negatively impacted
quality of care,
difficulties
communicating with
healthcare providers, and
difficulties accessing
pain management postdischarge

L: Possible self-selection
bias of sample

16

Rich, 2009

Explore the
experiences of young
violently injured
Black men

Ethnography,
semi-structured
interviews

n=20; Black men
hospitalized for
violent injury

Hospitals in
Boston

Young Black men are at
higher risk for violent
injury and are often
assumed by healthcare
providers to be complicit
in crime when they are
injured, which can lead
to suboptimal care.

S: Trusting relationships
built with participants,
large amount of data
collected

55

14

Author

Objective

Design

Sample

Setting

Findings

Strengths &
Limitations
S: Large sample from
across US
L: Unclear what is meant
by “modified” grounded
theory methodology,
sample is only
physicians, participants
were at a professional
conference and that may
have affected what they
were willing to share.

Sinnenberg et
al. 2017

Explore factors
influencing physician
pain treatment
decision making
(specifically opioids)
in ED

“Modified”
grounded
theory, semistructured
interviews

n=52; ED
physicians at
national
conference

Physicians
work at EDs
across US

Participants reported that
opioid pain treatment
decisions are complex,
and that the patient’s
report of pain was less
influential than the
physician’s own
interpretation of the
patient’s pain. Ability to
relate to and trust patient
important.

18

Staton
et al. 2007

Assess the association
of patient
characteristics (race,
age, gender) and the
underestimation of
chronic pain by
physicians (difference
in patient vs.
physician pain rating
on 0-10 scale by 2+
points)

Descriptive
cross-sectional

n=463; patientphysician dyads
at 12 primary
care clinics,
patients aged 18+
with chronic noncancer pain (39%
Black patients,
47% White
patients)

12 primary
care clinics
across US

Black race significantly
associated with physician
underestimation of
patient pain (OR=1.92,
95% CI 1.31-2.81, p<.05)

S: Multi-site
L: Only chronic pain

19

Trawalter
et al. 2012

Assess whether RNs
and nursing students
perceive the pain of
Black and White
individuals differently

Descriptive
cross-sectional

n=56; RNs and
nursing students
from across the
US (67% RNs,
33% nursing
students; 88%
White
participants, 7%
Black
participants)

Participants
recruited
from nursing
schools
across the
US; online
survey with
virtual
humans and
vignettes

Participants rated the
pain of Black individuals
as lower than the pain of
White individuals
(F=4.90, p=0.03, d=0.72)

L: Small sample size;
possibility of sampling
bias; virtual humans and
vignettes

56

17

Author
20

Wandner
et al. 2014

Design

Sample

Setting

Findings

Assess the impact of
patient characteristics
(race, age, gender) on
providers’ perception
of virtual patients’
low back pain

Descriptive
cross-sectional

n=193;
physicians and
nurses (58%
nurses; 71%
female; 69%
White
participants, 11%
Black
participants)

Online
virtual
human and
vignette
study, 76%
of
participants
from Florida

Participants rated the
pain of Black patients as
higher than White
patients (F=21.10,
p<0.001, ŋp2=0.11) and
the pain of male patients
are higher than female
patients (F=20.97,
p<0.001, ŋp2=0.10)
Participants stated that
they would be more
likely to give opioids to
Black patients than
White patients (F=16.02,
p<0.001, ŋp3=0.08) and
male patients than female
patients (F=14.07,
p<0.001, ŋp2=0.07)
Nurses were more likely
than physicians to state
that they would order
opioids (F=14.08,
p<0.001, ŋp2=0.07)

Strengths &
Limitations
S: Both physicians and
nurses included
L: Virtual humans and
vignettes; did not assess
dosage of opioids
participants are willing to
prescribe; all vignettes
are focused on low back
pain; possible sampling
bias
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Objective

Table 2.2:
Mixed Methods Appraisal Tool (Hong et al., 2018)
Quantitative Studies
Are there
clear research
questions?

Lee, 2013
Liebschutz
et al. 2010
Patton
et al. 2016

Y

Y

Researchers report
using grounded
theory methodology
but do not present a
theory generated by
the work
Y

Rich, 2009

Y

Y

Sinnenberg et
al. 2017

Y

Y

Y
Y

Researchers report
using grounded
theory methodology
but do not present a
theory generated by
the work

Are the data
collection methods
adequate to address
the research
question?
Y
Y

Are the findings
adequately
derived from the
data?
Y
Y

Is the interpretation
of results
sufficiently
substantiated by
data?
Y
Y

Is there coherence
between data
sources, collection,
analysis and
interpretation?
Y
Y

Y

Y

Y

Y

Y

Y

Y

Y

Y

Y

Y

Y
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Is the approach
appropriate to
answer research
question?

Y
Y

Do the collected
data allow to
address the
research
questions?
Y
Y

Table 2.3:
Mixed Methods Appraisal Tool (Hong et al., 2018)
Quantitative & Mixed Methods Studies
Is randomization
appropriately performed?

Are the groups
comparable at
baseline?

Are there
complete
outcome data?

Y

Do the collected
data allow to
address the research
questions?
Y

Unknown

Unknown

Y

Y

Y

Are there
clear research
questions?

Quantitative
RCTs

Are there
clear research
questions?

Drwecki et al.
2011
Burgess
et al. 2014
Quantitative
Descriptive

Did the participants
adhere to the
assigned
intervention?
Y

Unknown

Y

N

Y

Is the sampling strategy
relevant to address the
research question?

Is the sample
representative of the
target population?

Are the
measurements
appropriate?

Is the risk of
nonresponse bias
low?

Y

The sample only
includes MDs and
dentists; did not
stratify based on
pain management
training
Only studied
patients in one city
Only studied
patients who
presented to 2 urban
EDs with long-bone
fracture
Prescribers other
than MDs excluded

Vignettes may
not
adequately
mirror clinical
scenarios

Unknown

Is the statistical
analysis appropriate
to answer the
research question?
Y

Y

N/A, chart review

Y

Y

N/A, chart review

Y

Vignettes may
not
adequately
mirror clinical
scenarios
Y

40% response rate

Y

N/A, chart review

Y

Bartley
et al. 2015

Y

Do the collected
data allow to
address the research
questions?
Y

Becker
et al. 2011
Bernstein et
al. 2009

Y

Y

Y

Y

Y

Y

Burgess
et al. 2008

Y

Y

Y

Burgess
et al. 2013

Y

Y

Y

Sample was from
VA hospital records
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Y

Are outcome
assessors blinded to
the intervention
provided?
N

Y

Y

Sample was from
VA hospital records
Prescribers other
than MDs excluded
Prescribers other
than MD residents
and fellows
excluded

Y

Y

Y

Y

Y

Y

Hoffman
et al. 2016

Y

Y

Y

Providers other than
medical students
and MD residents
excluded

Staton
et al. 2007

Y

Y

Y

Providers other than
MDs excluded

Trawalter
et al. 2012

Y

Y

Sampling strategy
unclear

Sample is a mix of
RNs and nursing
students, mostly
White

Wandner
et al. 2014

Y

Y

Sampling strategy
unclear

Mix of MDs and
nurses, all living in
Florida

Mixed
Methods

Are there
clear research
questions?

Do the collected
data allow to
address the research
questions?

Is there an adequate
rationale for using a
mixed methods design to
address the research
question?

Are the different
components of the
study effectively
integrated to answer
the research
question?

Hollingshead
et al. 2015

Y

Y

Y

Y

Y

N/A, chart review

Y

Y

Y

Y

Vignettes may
not
adequately
mirror clinical
scenarios
Vignettes may
not
adequately
mirror clinical
scenarios
Y

Y

Y

Unknown

Y

Y

Y

Unknown

Y

Unknown

Y

Are divergences and
inconsistencies
between quantitative
and qualitative results
adequately
addressed?

Do the different
components of the
study adhere to the
quality criteria of
each tradition of the
methods involved?

Y

Little detail about
qualitative method

Vignettes may
not
adequately
mirror clinical
scenarios
Vignettes may
not
adequately
mirror clinical
scenarios
Are the
outputs of the
integration of
qualitative
and
quantitative
components
adequately
interpreted?
Y
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Y

Hausmann et
al. 2013
Heins et al.
2010
Hirsh
et al. 2015

Figures
Figure 2.1: Literature Search Diagram
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Figure 2.2: Theoretical Model
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CHAPTER 3
The Impact of Intentionality of Injury and Substance Use History on Receipt of
Discharge Opioid Medication in a Cohort of Seriously Injured Black Men
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Abstract
Background: Seriously injured people with undertreated pain may have difficulty
integrating back into their lives and communities, engaging with follow-up care, and
returning to work and family responsibilities. The recent increase in the availability of
both pharmaceutical pain medications and illicit opioids in neighborhoods and on
streets across the United States (US) means that those with undertreated pain may selftreat in ways that put them at risk, especially when alternative treatments are
inaccessible. Black patients are less likely than White patients to receive pain
treatment, especially opioid pain treatment, for both acute and chronic pain. Black
people, especially Black men, are at higher risk than other populations of being
“assumed criminal” regardless of any actual involvement in criminal activity.
Additionally, certain injury and patient characteristics such as intentionality of injury
and substance use history may cause healthcare providers to suspect criminal
involvement, and these suspicions may impact pain treatment decisions.
Purpose: This study sought to describe the factors that predict the receipt of discharge
opioid prescription in a cohort of seriously injured Black men. We hypothesized that
men with intentional injuries and substance use histories would be less likely to
receive opioids at discharge than men with unintentional injuries and no substance use
histories. Additionally, we hypothesized that of men who receive opioids at discharge,
men with intentional injuries and substance use histories would receive lower
morphine milligram equivalent doses than men with unintentional injuries and no
substance use histories.
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Methods: A secondary analysis of data from the Psychological Effects of Injuries in
Injured Black Men Study (n=623) was conducted. This database included 346
intentionally injured and 277 unintentionally injured men who were hospitalized for
their injuries. Logistic and linear regression were used to examine relationships among
discharge pain prescriptions, intentionality of injury and substance use/overuse
history.
Results: After controlling for age, injury severity, pain score, length of hospital stay
(LOS), insurance type, and year of study, receipt of opioids at discharge was not
impacted by injury intent. However, patients who self-reported substance overuse
were less likely to receive opioids at discharge than those who did not report overuse.
Self-reported substance use not characterized as overuse did not impact receipt of
opioids. Patients with higher injury severity, higher pain scores, and longer LOS were
more likely to receive opioids at discharge. Of patients who received opioids, injury
intent, substance use and substance overuse history did not impact discharge dosages.
Patients with higher pain scores and longer LOS received higher dosages than those
with lower scores and shorter LOS. Patients who were enrolled in the later years of the
parent study received lower opioid doses at discharge, reflecting national trends in
opioid prescribing.
Conclusions: Self-reported substance overuse was associated with lower odds of
receiving opioids at discharge in this cohort of seriously injured Black men. However,
self-reported substance use that was not characterized as overuse and injury intent did
not impact the receipt of opioids. Patients with higher pain scores and injury severities
and longer LOS were more likely to receive opioids at discharge, and higher pain
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scores and longer LOS were associated with higher dosages among patients who
received opioids at discharge.
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Introduction
As emergency care for severely injured patients improves, more patients are
surviving serious injuries and reentering the community (Cameron, 2012; Gruen,
Gabbe, Stelfox & Celso, et. al., 2006). Many of these patients require ongoing pain
treatment upon discharge from the hospital as their injuries continue to heal at home,
and inadequately treated pain can lead to negative physical, mental, social, and
financial outcomes (Holmes, et al., 2013; Institute of Medicine, 2011; Velmahos, et
al., 2019). At the same time, fears about potential for misuse or diversion of opioid
pain medications in light of the current United States (US) opioid crisis have impacted
clinical practice and providers have become more cautious and restrained in their
prescribing (Clarke, Skoufalos & Scranton, 2016; Haytham, et al., 2017).
Certain patients are at higher risk for undertreatment of pain; for example,
Black patients are less likely to be treated for traumatic, surgical, and chronic pain
than White patients with comparable illness and injury (Anderson, Green & Payne,
2009; Meghani, Byun & Gallagher, 2012). Black patients are also less likely to be
prescribed opioids than White patients, despite a lack of substantive evidence that
Black patients are at higher risk of opioid misuse (Meghani, Byun & Gallagher, 2012;
Substance Abuse and Mental Health Services Administration, 2014), and physicians
are more likely to underestimate the pain of their Black patients versus White patients
(Staton, et al., 2007). It is possible that the assumed criminality of certain patients due
to stereotyping and bias is one factor that may influence the receipt of pain treatment
(Aronowitz, et al., See Chapter 2). However, there is a gap in the research exploring
how certain patient and injury characteristics such as substance use history or
67

intentionality of injury may impact the pain treatment of injured Black men. The
purpose of this study was to determine what factors are associated with variations in
the receipt of discharge opioid prescriptions in a cohort of Black men hospitalized for
serious injury.
Black men are more likely than other demographic groups to be assumed
criminal in US society, regardless of actual criminal background (Muhammad, 2011;
Oliver, 2003; Owusu-Bempah, 2017). Although the phenomenon is not new
(Muhammad, 2011), recent media reports have highlighted instances of White people
calling the police when they witness Black people engaging in benign, everyday
activities because of the conflation of Blackness with crime (Caron, 2018; Stevens,
2018; Taylor, 2018). Previous research has highlighted the stigma perceived by Black
patients hospitalized with intentional injuries, like gunshot wounds (Liebchutz, et al.,
2010; Patton, et al., 2019), and that healthcare providers may assume that intentionally
injured Black men are involved in criminal activities, which impacts the empathy they
extend in healthcare encounters (Rich, 2009). Rich (2009) hypothesizes that providers
may have a harder time empathizing with patients suffering from intentional injuries
such as gunshot wounds, as providers are not likely to live in neighborhoods where
these acts of violence are common. This lack of understanding may cause providers to
assume that patients were involved in crime or “did something” to warrant their
injuries (Rich, 2009).
The interplay between racial bias, assumed criminality and traumatic injury
may have a direct impact on how Black patients with specific kinds of injuries are able
to access the classes of pain medications often associated with misuse and abuse.
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Black people are six to ten times more likely than White people to be incarcerated for
substance-related offenses, despite the fact that Black and White people use illicit
substances at comparable rates (Alexander, 2010; Netherland & Hansen, 2017,
Substance Abuse and Mental Health Services Administration, 2014). While only
12.5% of US citizens who use substances are Black, Black people represent 33% of
the population incarcerated for substance-related offenses (NAACP, 2018). These
statistics point to the racialized ways in which substance use is viewed. While
substance abuse is a rapidly growing public health issue across the US population, it is
much more likely to be treated as a criminal justice concern, rather than a target for
healthcare intervention, when Black people suffer from it (Netherland & Hansen,
2017).
Specific Aim and Hypothesis
The specific aims of this study were to:
1. Examine which factors predict the receipt of discharge opioid prescriptions in a
cohort of seriously injured Black men.
a. Hypotheses:
i. Men with intentional injuries and substance use histories are
less likely to be discharged on opioids than men with
unintentional injuries and no substance use histories.
ii. Of those discharged on opioids, men with intentional injury and
substance use histories will receive lower morphine equivalent
doses than men with unintentional injuries and no substance use
history.
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Methods
Description of Parent Study
Parent Study Design. This study was a secondary analysis of data from the
Psychological Effects of Injuries in Injured Black Men Study (ERRI Study). The
parent study enrolled a cohort of 623 seriously injured Black men, 54.5% of whom
were intentionally injured and 45.5% of whom were unintentionally injured. The
specific aims of this prospective cohort study were to test a predictive screener for
development of post-traumatic stress disorder (PTSD) and depression post-injury, to
evaluate the interplay of peri-traumatic subjective experiences and risk and protective
factors that predict psychological symptom severity, and to explore attitudes towards
seeking help for psychological symptoms.
Parent Study Sample. Eligible patients were Black men, 18 years of age and
older, English speaking, and residing in the Greater Philadelphia metropolitan area.
All participants had sustained acute traumatic injuries (ICD-9 codes 800-995) that
were severe enough to require hospitalization. Exclusion criteria were central nervous
system (CNS) injury or serious psychotic disorder (DSM 5 axis 1 diagnoses), injury
caused by suicide attempt/suicidal ideation, or if currently receiving treatment for
PTSD or depression.
The sample was comprised of consecutively enrolled injured men who met
study criteria during admission to a trauma center at two hospitals in Philadelphia
from 2013-2017. Patients were vetted for eligibility and approached for consent at
which time the study was explained and all questions were answered. A trained
enrollment nurse then obtained informed consent. Participants agreed to be
interviewed during hospitalization and three months after hospital discharge, and to
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allow access to electronic health records (EHR) to obtain injury-related medical
information.
Parent Study Procedure. Once consent was obtained, research staff were
notified and baseline interviews were scheduled. Baseline interviews took place in
private patient rooms at the hospital and included the collection of demographics and
injury data, the predictive screeners for PTSD, information about peri-traumatic
subjective experiences, and risk and protective factors. Interviews took approximately
one hour to one hour and a half to complete. Participants received a $30 gift card at
the completion of the interview and were scheduled for a 3-month follow-up
interview. The 3-month interviews were completed in a location of the participant’s
choosing. Interviews predominately took place at participants’ homes however some
interviews were conducted at the research offices or in a public location with a private
space.
Description of Study
This secondary data analysis included 623 patients from the ERRI study. We
used data from baseline interviews and the participants’ EHR, all contained within the
parent study dataset. Intentionality of injury, self-reported substance use, urine drug
screens, discharge analgesic orders, demographic characteristics, year of participation
in ERRI study, injury type, injury severity, length of stay (LOS) and in-hospital pain
ratings for the 24 hours prior to discharge were extracted from the parent study data
set. All data relevant to this secondary analysis were provided by the PI of the parent
study upon receiving institutional review board approval. See Table 3.1 for a table of
the variables.
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Instruments & Measurement
Independent variables. Intentionality of injury was coded by standard
definition according to mechanism of injury by the ERRI study data manager. In the
few cases that required adjudication, the ERRI study PI and data manager made a joint
determination. Presence of substance use history was determined by two measures that
explored substance use history at baseline interviews: self-report of substance use in
the prior 6 months and self-report of substance overuse, which was determined by an
affirmative answer to the question: “during the past 6 months, have you felt that you
use too much alcohol or drugs?” If participants answered yes to this question, they
were asked which substances they felt they used too much of. To assess the
opportunity to triangulate self-reported data, we examined the availability of urine
drug screens for each cohort member at hospital admission. Because only 278 patients
were administered urine drug screens and many patients are given pain medications
and/or benzodiazepines in transit to the hospital, this variable proved less useful than
self-reported substance use. Thus, self-reported substance use and overuse were the
substance use variables used in the final models.
Outcome variables. To determine discharge prescription dose, we first
examined all discharge medication orders and extracted opioid medications. We used
a morphine milligram equivalents (MME) calculator to convert all opioid dosages to
morphine equivalents (Agency Medical Directors’ Group, 2015; Centers for Disease
Control, 2018a). Morphine milligram equivalent calculators use the type of opioid,
milligram dose per day and morphine milligram equivalent conversion factor to
calculate MME values. Morphine milligram equivalent conversion factors are
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predetermined values assigned to each type of opioid for the purpose of dosage
conversion (Centers for Medicare and Medicaid Services, 2018).
Covariates. Injury severity in the parent study was assessed by trauma
registrars using the Abbreviated Injury Scale (AIS). The AIS ranks the severity of
injuries on a 1-6 scale (1 is minor, 6 is most severe), measuring injuries in 6 body
systems separately (head/neck, face, thorax, abdomen, extremities, external)
(Committee on Injury Scaling, 1998). The AIS ratings are then used to calculate an
Injury Severity Score (ISS), summing the square of the most severe injury across three
body systems. The summed score ranges from 1-75 (1 is most minor and 75 is
incompatible with life) (Baker, et al., 1947). These scores are grouped into categories,
with scores <9 defined as minor, scores 9-15 defined as moderate, scores 16-25
defined as severe, and scores >25 defined as very severe (Brasel, deRoon-Cassini &
Bradley, 2010). The ISS allows for comparisons of severity across body systems. Due
to the small number of participants in the parent dataset with very severe injuries, we
combined participants with injury severity scores ≥16 into one “severe” category,
resulting in three severity categories.
The highest pain score reported (on a 0-10 numeric rating scale) during the 24
hours prior to discharge was used, as an average of all scores recorded may have been
skewed by low scores recorded after the administration of pain medication. The
hospitals from which participants were recruited for the parent study have similar
policies about pain assessment, which involve mandatory assessment by RNs every 812 hours, at a minimum. This variable was transformed into a categorical variable by
labelling scores ≤4 as mild, scores >4 & ≤7 as moderate, and scores >7 as severe,
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which reflects the practice in many hospitals of using standing orders for in-hospital
pain treatment that follow similar scales.
Length of stay (LOS) was defined as the number of days that a participant was
hospitalized. It was categorized as 1-3 days, 4-7 days, 8-14 days, and >14 days. This
variable was included because participants are likely to have received opioid pain
treatment during their hospitalization. The length of exposure to opioids may impact
discharge prescriptions as patients can develop a tolerance to opioids, and providers
might take this into consideration when planning discharge pain treatment. Longer
LOS is also likely related to the medical needs of a patient, which providers might also
consider when planning discharge pain treatment. Age and insurance status were
collected during ERRI study surveys. We included age because of the possibility that
it could impact provider beliefs about risk of substance misuse or diversion. Insurance
status was included because of the potential impact of patients’ ability to pay for
medications on provider treatment decisions. The year that patients participated in the
ERRI study was included to measure changes in prescribing practices over time.
Power Analysis
The sample size for this study was determined by the sample size of the parent
study. The parent study included 623 participants, 280 of whom were unintentionally
injured (45.5%) and 343 of whom were intentionally injured (54.5%). This secondary
analysis was powered off of the primary outcome discharged on opioids (yes/no),
using PASS. See Appendix B for additional detail related to the power analysis.
Data Analysis
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STATA 15.1 was used for data management and statistical analysis. Chisquare tests were used to compare the proportion of those who were intentionally
injured and prescribed opioids with the proportion who were unintentionally injured
and prescribed opioids, as well as the proportion of those who reported substance use
or overuse and were prescribed opioids with the proportion who did not report
substance use or overuse and were prescribed opioids. We then used logistic
regression models to estimate the proportion of men who were prescribed opioids in
each group in order to address hypothesis: Men with intentional injuries and substance
use histories are less likely to be discharged on opioids than men with unintentional
injuries and no substance use histories. T-tests and linear regression models were used
to compare the morphine milligram equivalent doses in each group to address
hypothesis: Of those discharged on opioids, men with intentional injury and substance
use histories will receive lower morphine equivalent doses than men with
unintentional injuries and no substance use history.
Results
We first examined all variables with descriptive statistics (see Table 3.2). The
sample of participants who received opioids differed significantly from the sample
who did not receive opioids. Patients who received opioids were younger and more
likely to have penetrating injuries, longer LOS, higher injury severities, and higher
pain scores than those who did not receive opioids. Patients who received opioids
were also less likely to have self-reported overuse of alcohol. In addition, patients with
intentional injuries were more likely to receive opioids than patients with unintentional
injuries. See Appendix A for a descriptive table organized by intent of injury.
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Hypothesis 1
The outcome variable to estimate the proportion of men who were prescribed
opioids in each group was discharged on opioids (yes/no). Independent variables were
intentionality of injury, substance use history, and the interaction of intentionality and
substance use history. The interaction term was not significant (p=0.76) and was
removed from the model. We first examined all variables individually in bivariate
models (see Table 3.3). We then constructed the adjusted model, adjusting for age,
injury severity, pain score, LOS, insurance status, and year of study. Injury severity,
pain scores, and LOS had categories for “no data” as 32 participants had missing
injury severity data, 66 participants had missing pain score data, and 30 had missing
LOS data.
While intentionality of injury was significant in the bivariate model (patients
with intentional injuries were more likely to receive opioids at discharge, OR=1.66,
95% CI 1.14-2.43), intentionality was no longer significant in the adjusted model.
Self-reported substance use was not significant in bivariate or adjusted models.
However, self-reported substance overuse was significant in the bivariate model
(OR=0.60, 95% CI 0.40-0.90). Self-reported alcohol overuse was the only substance
that significantly impacted receipt of opioids (OR=0.39, 95% CI 0.24-0.62). In the
adjusted model, which included intent, age, injury severity, pain score, insurance
category, reported substance use, reported substance overuse, and year of study, only
substance overuse, injury severity, pain rating, and LOS were significant (see Table
3.3). Patients who reported substance overuse were less likely to receive opioids at
discharge than those who did not report overuse (OR=0.49, 95% CI 0.27-0.87).
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Patients with moderately severe injuries were more likely to receive opioids at
discharge than patients with mild injuries (OR=3.75, 95% CI 1.97-7.13). However,
patients with severe injuries were not significantly more likely to receive opioids.
Patients with moderate pain were more likely to receive opioids than patients with
mild pain (OR=4.37, 95% CI 2.14-8.91), as were patients with severe pain
(OR=12.02, 95% CI 5.80-24.94). Patients hospitalized for 4-7 days were more likely
to receive opioids than those hospitalized for less than 4 days (OR=2.48, 95% CI 1.354.55), as were patients hospitalized for 8-14 days (OR=5.20, 95% CI 2.01-13.48).
We then imputed the missing data for injury severity, pain scores and LOS.
Thirty-two participants had missing injury severity data, and 66 participants had
missing pain score data, and 30 had missing LOS data. In the imputed model,
substance overuse, injury severity, pain, year of study, and LOS were significant (see
Table 3.4). Self-reported substance overuse was associated with lower odds of
receiving opioids at discharge (OR=0.46, 95% CI 0.26-0.81). Moderate injuries were
associated with significantly higher odds of receiving opioids at discharge (OR=4.43,
95% CI 2.30-8.52). Increasing pain scores were also associated with significantly
higher odds of receiving opioids at discharge (moderate pain: OR=4.54, 95% CI 2.279.12; severe pain: OR=13.33, 95% CI 6.45-27.55). Increasing LOS was associated
with LOS higher odds of receiving opioids at discharge (LOS 4-7 days: OR=3.34,
95% CI 1.86-5.99; LOS 8-14 days: OR=6.84, 95% CI 2.58-18.12; LOS > 14 days:
OR=4.27, 95% CI 1.39-13.13). Patients discharged in the year 2014 were less likely to
receive opioids than those discharged in 2013 (OR=0.56, 95% CI 0.31-0.99).
Hypothesis 2
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We used linear regression models to compare the morphine milligram
equivalent doses among men who received an opioid prescription at discharge. Four
hundred and eighty-one participants received opioids at discharge. The outcome
variable was morphine milligram equivalent doses and the independent variables were
intentionality of injury, substance use history, and the interaction of intentionality of
injury and substance use history. The interaction term was not significant (p=0.80) and
was removed from the model. We first examined all variables with bivariate models
(see Table 3.5). The adjusted model included intentionality, age, injury severity, pain
score, LOS, insurance category, substance use history, substance overuse history, and
year of study. Only age, pain score, LOS, and year of study were significantly
associated with morphine milligram equivalent dosage at discharge (see Table 3.5).
Increasing age was associated with decreasing doses of opioids at discharge (β=-0.38,
95% CI -0.74- -0.01). Moderate pain was not associated with a significantly higher
dose of opioids, but severe pain was (β=32.53, 95% CI 12.45-52.62). Increasing LOS
was associated with increasing dosages at discharge (LOS 8-14 days: β=29.14, 95%
CI 14.52-43.77; LOS >14 days: β=22.22, 95% CI 0.84-43.59). Patients who were
discharged in 2016 had significantly lower doses of opioids than those discharged in
2013 (β=-19.11, 95% CI -33.50- -4.71). No other years were associated with a
significant difference in opioid doses at discharge. This model explained 6.7% of the
variation in morphine milligram equivalent doses at discharge.
After imputing for missing data for injury severity, pain scores, and LOS, age,
pain severity, LOS, and year of study remained significant (see Table 3.4). Increasing
age was associated with decreased dosages at discharge (β=-0.39, 95% CI -0.75- -
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0.02). Severe pain was associated with increased dosages at discharge (β=30.76, 95%
CI 10.83-50.69). Moderate pain was not associated with a significant increase in
opioid dosage. Increasing LOS was associated with increasing dosages at discharge
(LOS 8-14 days: β=29.02, 95% CI 14.48-43.55; LOS>14 days: β=23.92, 95% CI 2.3045.54). In addition, patients discharged during the year 2016 received lower opioid
dosages than those discharged during 2013 (β= -17.60, 95% CI -31.80- -3.40) (see
Figure 3.1).
Discussion
Men in this cohort who reported substance overuse were less likely to receive
opioids at discharge. Neither self-reported substance use that was not categorized as
overuse nor injury intent impacted receipt of an opioid prescription. Patients with
more severe injuries, higher pain scores, and longer LOS were more likely to receive
opioids than those with milder injuries, less severe pain, and shorter LOS. Increasing
pain ratings and LOS were also associated with higher doses of opioids at discharge.
Imputation changed our results slightly. Patients discharged in the year 2014 were less
likely to receive opioids than those discharged in 2013, and patients with LOS>14
days were more likely to receive opioids at discharge. Imputation did not have an
impact on MME dosage at discharge. Overall, these results suggest that providers
treating this group of injured Black men based their discharge pain treatment decisions
on level of pain, severity of injury, and LOS, and did not withhold pain medication
based on intent of injury. In addition, the prescribing practices of providers treating the
participants in our study did not seem impacted by patient self-reported substance use
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history not characterized as problematic, assuming the providers were aware of their
patients’ substance use histories.
Although much of the media covering the opioid crisis has highlighted cases of
“drug naïve” individuals who become addicted to opioids after receiving a
prescription, nearly 90% of patients who develop so-called iatrogenic opioid use
disorder report a history of psychoactive substance use prior to first using opioids
(Cicero, Ellis & Kasper, 2017). A recently published study exploring provider
decision-making related to pain treatment found that emergency medicine physicians
consider past or present substance use when making pain treatment decisions
(Sinnenberg et al., 2017). In addition, the use of prescription drug monitoring
programs (PDMPs) has increased since the early 2000’s and may reduce opioid
prescribing by allowing providers to determine if patients are receiving multiple
prescriptions for controlled substances (Bao et al., 2016). Recent systematic review
evidence calls into the question the effectiveness of PDMPs at impacting opioid
prescription, but they remain widely used (Wilson, et al., 2019).
Assuming that providers were aware of their patients’ substance use histories,
our results reflect provider concern related to substance overuse but suggest that
providers treating the patients in this cohort were not necessarily altering their pain
treatment discharge plans due to substance use alone. It is important to note that
substance use history and misuse/addiction are distinct phenomena, as individuals who
use substances may not engage in behavior that qualifies as problematic. While the use
of illicit substances is generally not viewed favorably in healthcare environments,
some providers clearly differentiate between use and misuse and may not have the

80

same concerns about patients who report using substances versus those with abuse
history. The only substance that had an impact on receipt of opioids (when reported
overused) was alcohol. This is likely due to the small numbers of patients who
reported overusing other substances. Providers are aware of the detrimental effects of
alcohol abuse and the risks associated with mixing alcohol and other substances, but it
is also possible that providers understand that the disease of addiction generalizes
across substance, such that patients who abuse alcohol are more likely to abuse
opioids and other substances than those who do not abuse alcohol (Cicero, Ellis &
Kasper, 2017; Jones & McCance-Katz, 2019).
Patients are more likely to underreport use of substances generally regarded as
more harmful or criminal (e.g. opioids versus marijuana or alcohol) (Bone et al.,
2016). In addition, individuals with reason to believe that they will face negative
consequences for their substance use (e.g. pregnant women and previously
incarcerated people) are especially likely to underreport (Bone et al., 2016; Garg et al.,
2016). It is possible that participants in this cohort were aware that endorsing
substance use or overuse might cause providers to withhold pain medication or
negatively impact their care in some other way. Injured Black patients (especially
intentionally injured Black patients) report feeling stigmatized by healthcare
professionals (Jacoby, 2015; Liebchutz, et al., 2010; Patton et al., 2019), and it is
possible that participants felt hesitant about revealing anything that might further this
stigmatization.
There was a trend towards decreasing MME dosages across all patients in the
sample over time. Patients discharged in 2016 received significantly lower dosages
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than in 2013. Figure 1 displays this trend clearly; no participants received opioid
dosages greater than 200 MME after 2015. The pattern of decreasing MME dosages
seen in this study reflects national trends in opioid prescribing. Opioid prescriptions
have been decreasing in both number of prescriptions per capita and MME dosage per
prescription since 2012, with a 20% reduction in MME/day dosages per capita in the
US between the years 2015-2017 (Guy et al., 2019). The 2016 CDC guidelines
recommend 90 MME daily limits for most patients with chronic pain, as well as
limiting the duration of prescriptions for acute pain to 7 days or less (Dowell,
Haegerich & Chou, 2016).
We are unaware of any other studies exploring the impact of injury intent on
receipt of opioids at discharge. However, other researchers have suggested the
possibility that intent may influence a provider’s assessment of a patient, leading them
to display decreased empathy towards a “vilified disrespected patient” versus an
“affluent respected” one, and that this lack of empathy may impact pain treatment
(Martin, 2000, pg. 79). While the stigmatization of certain patients due to a variety of
characteristics including injury intent has been documented in the qualitative literature
(Jacoby, 2015; Liebchutz, et al., 2010; Patton et al., 2019), pain treatment may not be
impacted by these biases. This may be due in part to the increasing protocolization of
pain care, particularly since the dawn of the opioid crisis (American Hospital
Association, 2017). It is also possible that providers at the hospital where the ERRI
study took place treat so many intentional injuries that they do not view these patients
differently than those injured unintentionally.
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This study had several limitations. Comparing the treatment of patients with
penetrating versus blunt injuries is difficult, as these injuries are medically quite
different. In the group of unintentionally injured patients, the number of patients with
penetrating injuries was very small (n=9). The number of intentionally injured patients
with blunt injuries was larger (n=61), but intentionality and mechanism were closely
related in this sample. Our evaluation of the impact of substance use history on receipt
of opioids at discharge was limited by how we measured substance use: self-reported
use and overuse of substances in the 6 months prior to injury. These data were
collected during the ERRI study and were not necessarily in the patients’ EHR, and it
is possible that providers were unaware of patient substance use if patients did not
report this use to clinicians at the hospital. In addition, participants may have
underreported substance use in an attempt to provide socially desirable responses or
because they were not comfortable sharing this information with the ERRI study staff.
Due to increased risk of substance use disorders among people with depression or
PTSD (Davis, Akihito, Newel & Frazier, 2008), the ERRI study exclusion of patients
currently receiving treatment for these conditions may have resulted in lower rates of
substance use/overuse in this sample. The parent dataset only included patients from
two trauma centers in one northeastern US city where gun violence is extremely
common. It is unclear if intent of injury might have a stronger impact on pain
treatment in a setting where providers are less experienced and/or comfortable treating
patients with gunshot wounds.
Future studies should explore the potential impact of injury intent and
substance use on receipt of opioids in a racially and geographically diverse sample.
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Because a large number of intentional injuries in our sample were gunshot wounds, we
are interested in whether results would differ at hospitals in areas where gunshot
wounds are less common or areas where gun ownership is widely accepted and
perceived as associated with legal ownership for the purposes of recreation or hunting.
Intentionality of injury might have less of an impact in patients who already
experience bias and are less likely to receive pain treatment due to their race, and we
are curious if injury intent impacts pain treatment in patients of other racial groups.
We acknowledge that assumed criminality of patients may impact care in subtle and
pernicious ways that are not reflected in simple quantitative data about receipt of
prescriptions, and do not believe that our results suggest that healthcare environments
are free from damaging stigma. As previously discussed, qualitative work in this area
reveals that intentionally injured Black patients report feeling stigmatized in
healthcare settings, which can impact the patient-provider relationship and patient trust
in the healthcare system (Jacoby, 2015; Liebchutz, et al., 2010; Patton et al., 2019;
Rich, 2009). Continued research investigating health outcomes as well as qualitative
studies exploring patient experiences and provider biases can help fill this knowledge
gap.
Conclusion
In a cohort of injured Black men hospitalized in a large northeastern US city
between the years of 2013-2017, receipt of discharge opioid prescriptions was not
impacted by intentionality of injury but by severity of injury, severity of pain, and
length of hospital stay. In addition, men who reported substance overuse were less
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likely to receive opioids at discharge. Providers prescribed lower dosages of opioids
over time, which mirrors national trends in opioid prescribing.
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Tables
Table 3.1: Table of Variables
Independent Variable
Intentionality of injury

Reported Substance Use History
Reported Substance(s) Used
Reported Substance Overuse
History
Reported Substances(s)
Overused
Dependent Variable
Receipt of Opioid
Dose of Opioid

Covariates
Injury Severity

Pain Score

Length of Stay (LOS)

Definition
Intentional injury is an injury
caused by another person during
a violent assault, while
unintentional injury is defined as
accidental and not intentionally
inflicted
Self-report of substance use in
prior 6 months
If participant reported substance
use history, which substance(s)
Self-report of overuse of
substances in prior 6 months
If participant reported substance
overuse history, which
substance(s)

Measurement
Dichotomous

Dichotomous
Categorical
Dichotomous
Categorical

Receipt of opioid prescription at
discharge
Dose of discharge opioid
medication prescribed per day,
in morphine milligram
equivalents

Dichotomous

The severity of a participant’s
injury

Injury Severity Scale,
Categorical (Mild: <9,
Moderate: ≥9 & ≤15, Severe:
≥16)
1-10 pain scale, Categorical
(Mild: ≤4, Moderate: >4 & ≤7,
Severe: >7)
Categorical (LOS 1-3 days, LOS
4-7 days, LOS 8-14 days,
LOS>14 days)
Categorical (Private, Medicaid,
Medicare, self-pay)

The highest pain score recorded
during the 24 hours prior to
discharge
The number of days a
participant was hospitalized

Converted to morphine
milligram equivalents,
Continuous

Insurance Status

Patient’s insurance status

Age

Age of participant in years

Continuous (18-90 years old)

Year of Study

The year that the participant was
enrolled in the ERRI study

Categorical (2013-2017)
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Table 3.2: Descriptive Statistics
Receipt of Opioids
All Patients
n=623
Characteristic

N (%)

N (%)

Did Not Receive
Opioids
n=142
N (%)

Age, mean (SD)
Insurance Type
Private

35.63 (14.89)

34.51 (14.00)

39.43 (17.08)

69 (11.08)

60 (12.47)

9 (6.34)

Public

200 (32.10)

146 (30.35)

54 (38.03)

Third Party

61 (9.79)

42 (8.73)

19 (13.38)

Self-Pay

261 (41.89)

208 (43.24)

53 (37.32

Unknown

32 (5.14)

25 (5.20)

7 (4.93)

329 (52.89)

235 (48.86)

94 (66.20)

293 (47.11)

246 (51.14)

47 (33.10)

Injury Type
Blunt
Penetrating
Injury Severity Score
(ISS)
Mild (ISS<9)

Received Opioids
n=481

P Value

.002
.059

<.001

<.001
293 (47.03)

197 (40.96)

96 (67.61)

Moderate (ISS≥9 & ≤15)

211 (33.87)

192 (39.92)

19 (13.38)

Severe (ISS≥16)

87 (13.96)

71 (14.76)

16 (11.27)

32 (5.14)

21 (4.37)

11 (7.75)

58 (9.31)

30 (6.24)

28 (19.72)

Moderate (>4 & ≤7)

180 (28.89)

145 (30.15)

35 (24.65)

Severe (>7)

319 (51.20)

290 (60.29)

29 (20.42)

No data
Length of Stay
1-3 days

66 (10.59)

16 (3.33)

50 (35.21)

263 (42.22)

168 (34.93)

95 (66.90)

4-7 days

193 (30.98)

166 (34.51)

27 (19.01)

8-14 days

97 (15.57)

89 (18.50)

8 (5.63)

>14 days

40 (6.42)

34 (7.07)

6 (4.23)

No data

30 (4.82)

24 (4.99)

6 (4.23)

Reported substance use in
past 6 mos.
Alcohol

476 (76.53)

369 (76.72)

107 (75.35)

.737

374 (60.03)

285 (59.25)

89 (62.68)

.464

Marijuana

215 (34.51)

174 (36.17)

41 (28.87)

.108

Opioids

27 (4.33)

24 (4.99)

3 (2.11)

.139

Cocaine

30 (4.82)

26 (5.41)

4 (2.82)

.206

No data
Highest Pain Score
Mild (≤4)

<.001

<.001
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157 (25.20)

110 (22.87)

47 (33.10)

.014

95 (15.25)

58 (12.06)

37 (26.06)

<.001

Marijuana

45 (7.22)

37 (7.69)

8 (5.63)

.405

Opioids

5 (0.80)

5 (1.04)

0 (0)

.223

Cocaine
Positive Urine Drug
Screen*
Marijuana

12 (1.93)

11 (2.29)

1 (0.70)

.228

113 (40.65)

86 (43.43)

27 (33.75)

.137

Opioids
Intent of Injury
Unintentional

70 (25.18)

55 (22.78)

15 (18.75)

.116
.008

277 (44.46)

200 (41.58)

77 (54.23)

Intentional

346 (55.54)

281 (58.42)

65 (45.77)

Reported overuse in past 6
mos.
Alcohol

Due to missing data, totals may not equal 623. T-tests were used for continuous variables and chi-square tests
were used for categorical variables.
*Urine drug screen was performed on 278 patients in the sample.
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Table 3.3: Odds of Receipt of Opioids at Discharge
Bivariate
Intentional Injury
Age
ISS

Odds Ratio
1.66

Standard Error
0.32

Adjusted Model
95% CI
(1.14, 2.43)b

Odds Ratio
1.12

Standard Error
0.33

95% CI
(0.64, 1.98)

0.98

0.01

(0.97, 0.99)c

1.00

0.01

(0.98, 1.01)

Moderate (≥9 & ≤15)

4.92

1.33

(2.90, 8.37)d

3.75

1.23

(1.97, 7.13)d

Severe (≥16)

2.16

0.66

(1.19, 3.91)b

0.83

0.36

(0.36, 1.95)

No data

0.93

0.36

(0.43, 2.01)

0.49

0.30

(0.15, 1.60)

Moderate (>4 & ≤7)

3.87

1.25

(2.05, 7.29)d

4.37

1.59

(2.14, 8.93)d

Severe (>7)

9.33

3.05

(4.92, 17.72)d

12.02

4.48

(5.80, 24.94)d

No data

0.30

0.12

(0.14, 0.64)b

0.50

0.23

(0.21, 1.22)

4-7 days

3.48

0.85

(2.15, 5.61)c

2.48

0.77

(1.35, 4.55)b

8-14 days

6.29

2.46

(2.92, 13.53)c

5.20

2.53

(2.01, 13.45)b

>14 days

3.20

1.48

(1.30, 7.91)a

2.95

1.22

(0.36, 7.11)

No data

2.26

1.07

(0.89, 5.73)

1.60

1.22

(0.36, 7.11)

Public

0.41

0.16

(0.19, 0.87)a

0.58

0.27

(0.23, 1.45)

Third-Party

0.33

0.15

(0.14, 0.80)a

0.74

0.41

(0.25, 2.21)

Self-Pay

0.59

0.23

(0.27, 1.26)

0.93

0.43

(0.38, 2.32)

Unknown

0.54

0.30

(0.18, 1.60)

1.36

1.09

(0.29, 6.50)

Reported
substance use in
past 6 months

1.08

0.24

(0.70, 1.67)

0.99

0.31

(0.54, 1.83)

0.60

0.13

(0.40, 0.90)a

0.49

0.14

(0.27, 0.87)a

2014

0.60

0.14

(0.38, 0.95)a

0.61

0.18

(0.34, 1.10)

2015

1.71

0.53

(0.93, 3.14)

1.21

0.47

(0.57, 2.58)

2016

1.31

0.40

(0.72, 2.37)

1.16

0.45

(0.54, 2.47)

2017
0.56
0.32
(0.18, 1.73)
0.32
0.23
Note: ap<.05, bp<.01, cp<.001, dp<.0001; significant values are bolded in adjusted column

(0.08, 1.27)

(Ref group: minor)

Pain Rating
(Ref group: minor)

Length of Stay
(Ref group: 1-3 days)

Insurance
(Ref group: private)

(Ref group: no reported
use)

Reported overuse
in past 6 months
(Ref group: no reported
overuse)

Year of Study
(Ref group: 2013)
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Table 3.4: Results with Imputed Values

Intentional Injury
Age

Odds of Receipt of Opioid at Discharge
OR
Std. Err.
95% CI
1.17
0.33
(0.67, 2.05)
0.99
0.01
(0.98, 1.01)

Morphine Milligram Equivalent Dose
Coef.
Std. Err.
95% CI
0.08
5.71
(-11.14, 11.29)
-0.39

0.19

(-0.75, -0.21)a

ISS
(Ref group: minor severity)

Moderate (≥9 & ≤15)

4.43

1.48

(2.30, 8.52)c

6.00

5.57

(-5.00, 16.91)

Severe (≥16)

0.82

0.36

(0.35, 1.92)

5.41

8.28

(-10.87, 21.69)

Moderate (>4 & ≤7)

4.55

1.61

(2.27, 9.11)c

13.40

10.55

(-7.35, 34.14)

Severe (>7)

13.33

4.92

(6.45, 27.55)c

30.76

10.14

(10.83, 50.69)b

4-7 days

3.34

0.99

(1.86, 5.99)c

7.16

5.97

(-4.57, 18.89)

8-14 days

6.84

3.40

(2.58, 18.12)c

29.02

7.39

(14.48, 43.55)c

>14 days

4.27

2.45

(1.39, 13.13)a

23.92

10.99

(2.30, 45.54)a

Public

0.43

0.20

(0.17, 1.08)

-3.23

8.30

(-19.47, 13.01)

Third-Party

0.54

0.29

(0.19, 1.57)

-5.16

10.99

(-26.56, 16.25)

Self-Pay

0.67

0.31

(0.27, 1.67)

-3.22

8.04

(-19.10, 12.57)

Unknown

0.62

0.44

(0.16, 2.47)

8.61

13.11

(-17.14, 34.38)

Reported substance
use in past 6 months

1.19

0.36

(0.65, 2.16)

-0.44

6.21

(-12.64, 11.75)

0.50

0.133

(0.26, 0.81)a

-3.53

6.25

(-15.82, 8.75)

2014

0.56

0.17

(0.31, 0.99)a

-1.05

6.45

(-13.74, 11.63)

2015

1.46

0.56

(0.68, 3.11)

-5.67

6.89

(-19.21, 7.87)

2016

1.28

3.40

(0.61, 2.68)

-17.60

7.23

(-31.80, -3.40)a

2017
0.37
0.26
(0.09, 1.47)
Note: ap<.05, bp<.01, cp<.001; significant values are bolded

-19.71

18.01

(-55.11, 15.54)

Pain Rating
(Ref group: minor pain)

Length of Stay
(Ref group: 1-3 days)

Insurance
(Ref group: private)

(Ref group: no use)

Reported overuse in
past 6 months
(Ref group: no reported
overuse)

Year of Study
(Ref group: 2013)
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Table 3.5: Change in Morphine Milligram Equivalents (MMEs)
Bivariate

Adjusted Model

β
5.68

Std. Error
5.01

95% CI
(-4.17, 15.53)

β
-0.02

Std. Error
5.74

95% CI
(-11.29, 11.26)

-0.37

0.18

(-0.72, -0.25)a

-0.38

0.19

(-0.74, -0.01)a

Moderate (≥9 & ≤15)

10.31

5.46

(-0.42, 21.04)

7.17

5.60

(-3.84, 18.17)

Severe (≥16)

20.95

7.45

(6.30, 35.60)b

8.24

8.32

(-8.11, 24.60)

No data

17.71

12.36

(-6.58, 42.01)

15.57

17.29

(-18.41, 49.54)

Moderate (>4 & ≤7)

12.74

10.75

(-8.39, 33.86)

14.57

10.66

(-6.38, 35.52)

Severe (>7)

28.46

10.28

(8.26, 48.67)b

32.53

10.22

(12.45, 52.62)b

No data

14.35

16.60

(-18.26, 46.96)

21.36

16.73

(-11.55, 54.27)

4-7 days

6.72

5.82

(-4.71, 18.14)

6.65

6.01

(-5.17, 18.46)

8-14 days

31.41

6.97

(17.72, 45.09)c

29.14

7.44

(14.52, 43.77)c

>14 days

22.04

10.00

(2.40, 41.67)a

22.22

10.88

(0.84, 43.59)a

No data

21.33

11.60

(-1.45, 44.12)

17.45

16.14

(-14.23, 49.17)

Public

-6.86

8.33

(-23.23, 9.50)

-2.78

8.30

(-19.09, 13.53)

Third-Party

-9.22

10.93

(-30.70, 12.25)

-4.33

10.91

(-25.76, 17.11)

Self-Pay

-2.35

7.96

(-18.00, 13.30)

-3.08

8.08

(-18.95, 12.80)

Unknown

6.34

12.93

(-19.07, 31.75)

-2.68

16.88

(-35.85, 30.49)

Reported
substance use in
past 6 months

0.82

5.86

(-10.68, 12.33)

-0.34

6.21

(-12.54, 11.87)

-1.03

5.89

(-12.61, 10.55)

-3.34

6.26

(-15.65, 8.97)

2014

-0.96

6.56

(-13.85, 11.92)

-1.99

6.48

(-14.73, 10.75)

2015

-1.39

6.81

(-14.77, 12.00)

-6.27

6.88

(-19.80, 7.26)

2016

-15.59

7.16

(-29.66, -1.52)a

-19.11

7.32

(-33.50, -4.71)b

2017
-10.94
17.63
(-45.58, 23.71)
-23.80
Note: ap<.05, bp<.01, cp<.001; significant values are bolded in adjusted column

18.07

(-59.30, 11.71)

Intentional Injury
Age
ISS
(Ref group: minor)

Pain Rating
(Ref group: minor)

Length of Stay
(Ref group: 1-3 days)

Insurance
(Ref group: private)

(Ref group: no reported
use)

Reported overuse
in past 6 months
(Ref group: no reported
overuse)

Year of Study
(Ref group: 2013)
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Figures
Figure 3.1: Effect of Time on Morphine Milligram Equivalent (MME) Dosages

96

Appendixes
Appendix A:
Descriptive Statistics by Intent of Injury

All Patients
n=623
Characteristic

Intentionally
Injured Patients
n=346
N (%)

N (%)

Intentionality of
Injury
Unintentionally
Injured Patients
n=277
N (%)

35.63 (14.89)

31.24 (11.88)

41.12 (16.39)

69 (11.08)

30 (8.67)

39 (14.08)

Public

200 (32.10)

110 (31.79)

90 (32.49)

Third Party

61 (9.79)

3 (0.87)

58 (20.94))

Self-Pay

261 (41.89)

181 (52.31)

80 (28.88)

32 (5.14)

22 (6.36)

10 (3.61)

329 (52.89)

61 (17.68)

268 (96.75)

Age, mean (SD)
Insurance Type
Private

Unknown
Injury Type
Blunt
Penetrating

<.001
<.001

<.001

293 (47.11)

284 (82.32)

9 (3.25)

Injury Severity Score (ISS)
Mild (ISS<9)

293 (47.03)

139 (40.17)

154 (55.60)

Moderate (ISS≥9 & ≤15)

211 (33.87)

125 (36.13)

86 (31.05)

Severe (ISS≥16)

87 (13.96)

64 (18.50)

23 (8.30)

No data

32 (5.14)

18 (5.20)

14 (5.05)

58 (9.31)

29 (8.38)

29 (10.47)

Moderate (>4 & ≤7)

180 (28.89)

97 (28.03)

83 (29.96)

Severe (>7)

319 (51.20)

194 (56.07)

125 (45.13)

Highest Pain Score
Mild (≤4)

P Value

<.001

.009

No data
Length of Stay
1-3 days

66 (10.59)

26 (7.51)

40 (14.44)

263 (42.22)

129 (37.28)

134 (48.38)

4-7 days

193 (30.98)

108 (31.21)

85 (30.69)

8-14 days

97 (15.57)

58 (16.76)

39 (14.08)

>14 days

40 (6.42)

27 (7.80)

13 (4.69)

No data

30 (4.82)

24 (6.94)

6 (2.17)

Reported substance use in
past 6 mos.
Alcohol

476 (76.53)

279 (80.87)

197 (71.12)

.004

374 (60.03)

213 (61.56)

161 (58.12)

.382

Marijuana

215 (34.51)

145 (41.91)

70 (25.27)

<.001

Opioids

27 (4.33)

17 (4.91)

10 (3.61)

.427

Cocaine

30 (4.82)

19 (5.49)

11 (3.97)

.378

.005
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157 (25.20)

93 (26.88)

64 (23.10)

.281

95 (15.25)

46 (13.29)

49 (17.69)

.129

Marijuana

45 (7.22)

34 (9.83)

11 (3.97)

.005

Opioids

5 (0.80)

3 (0.87)

2 (0.72)

.840

Cocaine

12 (1.93)

7 (2.02)

5 (1.81)

0.844

113 (40.65)

80 (50.63)

33 (27.50)

<.001

70 (25.18)

44 (27.85)

26 (21.67)

.240

Outcome Variables
Received Opioid at Discharge

481 (77.21)

281 (81.21)

200 (72.20)

.008

Morphine Milligram
Equivalent Dose, mean (SD)

102.13 (54.22)

104.49 (56.47)

98.81 (50.84)

.258

Reported overuse in past 6
mos.
Alcohol

Positive Urine Drug Screen*
Marijuana
Opioids

Due to missing data, totals may not equal 623. T-tests were used for continuous variables and chi-square tests
were
used for categorical variables.
*Urine drug screen was performed on 278 patients in the sample.
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Appendix B:
Power Analysis Table
A two-sided Z-test with unpooled variance has 80% power to detect the following
differences in the proportions of those who were unintentionally injured and received
opioids versus those who were intentionally injured and received opioids:
Power
0.80000
0.80000
0.80000
0.80000
0.80000
0.80000
0.80000
0.80000
0.80000

N1
280
280
280
280
280
280
280
280
280

N2
343
343
343
343
343
343
343
343
343

N
623
623
623
623
623
623
623
623
623

P1
0.1786
0.2976
0.4076
0.5118
0.6113
0.7063
0.7967
0.8812
0.9567

P2
0.1000
0.2000
0.3000
0.4000
0.5000
0.6000
0.7000
0.8000
0.9000

D1
0.0786
0.0976
0.1076
0.1118
0.1113
0.1063
0.0967
0.0812
0.0567

Alpha
0.0500
0.0500
0.0500
0.0500
0.0500
0.0500
0.0500
0.0500
0.0500

For example, based on this table, if the proportion of participants who received opioids
in the intentionally injured group (N2) was 0.10, there is 80% power to detect a
significant difference at the 0.05 alpha level if the proportion of patients who received
opioids in the unintentionally injured group (N1) was 0.1786.
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CHAPTER 4
Is it “True” Pain? Pain Treatment Discharge Planning for Seriously Injured Patients:
An Exploration of Provider Considerations
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Abstract
Background: The United States is currently experiencing an opioid crisis that
contributes to as many as 130 deaths per day. As a result of this crisis, healthcare
providers are increasingly aware of the ways in which prescribed opioids can be
misused and diverted. While the CDC has released guidelines for the treatment of
chronic pain with opioids, no such guidelines exist for the treatment of acute pain, and
clinical discretion is required. Qualitative work has found that the ways in which
healthcare providers perceive the “trustworthiness” of or are able to “relate to” their
patients can impact the prescription of pain medication including opioids in hospital
emergency departments. These perceptions may hinge on a multiplicity of
characteristics that include a patient’s race, ethnicity, gender, age, and presenting
health condition or injury. Little is known about if and how providers integrate
perceptions of their patients into their decisions to provide opioid prescriptions to
seriously injured patients at hospital discharge.
Purpose: To explore the factors that providers take into consideration when planning
discharge pain treatment for seriously injured patients.
Methods: Using a semi-structured guide, we interviewed 12 providers who prescribe
discharge medications for seriously injured patients at a trauma center in Philadelphia.
We used thematic analysis to interpret these interview data.
Results: Participants identified the importance of determining true pain, which was the
overarching theme that emerged in the analysis. Subthemes were reliable methods,
patient population, and consequences of not getting it right.
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Conclusions: The trauma providers we interviewed expressed the need to determine
whether patients were experiencing “true” pain by using a variety of different
methods. Providers believed that these methods were more helpful than a patient’s
self-reported pain scale rating and could help protect from over or under prescribing in
a patient population that they identified as especially likely to fabricate pain in order to
receive opioids to misuse or divert. Finally, these providers expressed concern about
the consequences of misjudging a patient’s pain and either over or under prescribing.
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Introduction
Opioid-related overdose deaths in the United States (US) have been increasing
since the introduction of OxyContin in the 1990’s (Gitis & Soto, 2018). Recent efforts
to fight the opioid crisis include CDC recommendations for providers to decrease
opioid prescribing, consult electronic prescription drug monitoring programs
(PDMPs), and carefully consider the risk of substance abuse and overdose related to
prescription opioids (Dowell, Haegerich & Chou, 2016). While these are important
steps to help curb opioid overprescribing, the widespread availability of prescription
and illicit opioids on the street has made it increasingly easy for people to acquire
these substances for recreation or pain self-treatment without a provider’s prescription
(Alford et al., 2016; Gitis & Soto, 2018). Despite a reduction in provider opioid
prescribing, the rate of overdose deaths per year continues to increase (Gitis & Soto,
2018). Concurrently, patients continue to experience and require analgesic therapies
for acute and chronic pain related to health-altering events like traumatic injuries.
No “hard and fast” guidelines currently exist for the treatment of acute pain
with opioids, and providers need to use clinical acumen and other perceptual cues to
inform their prescribing decisions. A recent qualitative study of emergency department
(ED) physicians describes the importance of how physicians perceive the
“trustworthiness” and relatability of their patients when making decisions to prescribe
pain medication (Sinnenberg, et al., 2017). Physician participants additionally shared
that they rarely take a patients’ self-report of pain into account and instead make
treatment decisions based on how much pain they believe the patient’s condition
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would generally cause. For example, one participant stated that he knew how much
pain a kidney stone caused because he had once experienced one himself (Sinnenberg,
et al., 2017). In addition to a provider’s expectations for pain burden, this illustrates
the role that “relatability” and perceived experiential concordance between patients
and providers may play in clinical pain medication prescribing practices. If providers
are unable to relate to patients due to characteristics including type of injury or
ailment, how might this impact the provider’s pain treatment decisions?
Both provider and patient characteristics, such as race and gender (and in the
case of providers, type of training and experience) can impact pain treatment decisions
(Aronowitz et al., under review, see Chapter 2). A patient’s history of substance use
and intentionality of injury may also influence provider pain treatment decisionmaking, as these factors may raise provider suspicion about a patient’s involvement in
criminal activity and risk for substance abuse and/or diversion (Aronowitz et al., under
review; Patton et al., 2016; Rich, 2009; Sinnenberg, et al., 2017). Since most research
about pain treatment decision-making focuses on the ED or the treatment of chronic
pain, little is known about providers’ pain treatment decision-making during hospital
discharge planning for seriously injured patients. In addition, there is a lack of
research focusing on the pain treatment decision-making of non-physician providers,
although they are often the individuals writing discharge orders.
An understanding of provider pain treatment decision-making is important.
Providers must balance responsible opioid prescribing practices that aim to protect
their patients and communities from the risks associated with opioid misuse with
meeting the goal of providing pain treatment that enables seriously injured patients to
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engage in the healing process. A possible consequence of increasingly cautious opioid
prescribing is undertreated pain, which can interfere with a patient’s ability to fulfill
personal responsibilities and possibly lead patients to seek opioids illicitly. It is
possible that providers’ efforts to curb opioid prescribing to patients they deem as “at
risk” for substance abuse could fuel pain treatment disparities in certain populations.
Specific Aim
The aim of this study was to explore the factors that providers take into
consideration when prescribing pain treatment during discharge planning for seriously
injured patients.
Methods
Research Design
We used inductive thematic analysis to explore the experiences of providers
who prescribe discharge pain medication and the factors they take into consideration
when planning discharge pain treatment for seriously injured patients. This method of
analysis allowed for discovery of meaningful similarities in the experiences of these
providers and the ways they discuss the process of planning pain treatment for injured
patients (Braun & Clarke, 2012). An inductive approach requires that analysis stay
close to what is in the data, with themes coming directly from the data (Braun &
Clarke, 2012).
Sample
We purposively recruited a sample of advanced practice providers (nurse
practitioners and physician assistants) and physicians who routinely prescribe
discharge medications at a trauma center in Philadelphia, Pennsylvania for patients
who have sustained acute, serious injury. Twelve (12) providers were interviewed.
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The sample consisted of 7 advanced practice providers and 5 physicians. The average
age was 41.5 years (SD: 11.1), average number of years as a provider was 11.6 (SD:
7), and the average number of years working as a provider in trauma was 8.8 (SD:
6.6).
Procedures
The study was approved by the human subjects review board at the University
of Pennsylvania. Participants were recruited using multiple strategies. With permission
from trauma department chairs and managers, we presented our study at two team
meetings. Potential participants were asked to contact the PI (SA) if they were
interested in participating. After recruiting an initial sample of participants, we used
snowball sampling to recruit additional eligible providers into our study.
Using a semi-structured guide (Appendix A), the PI (SA) conducted and audiorecorded participant interviews. All participants provided verbal informed consent
prior to participation and chose to be interviewed in private rooms at the hospital
where they worked. Interviews lasted between 20-40 minutes. Each interview was
structured around open-ended questions that elicited participants’ experiences and
decision-making around discharge pain treatment for seriously injured patients. As the
study progressed, some additional questions and probes were added to the interview
guide as informed by early data analysis (Willis, et al., 2016). Interviews continued
until descriptive saturation was reached, which occurred when the PI recognized
consistent similarities in participant descriptions of their experiences and perspectives
(Morse, 2015; Saunders et al., 2018). Field notes describing participant body language
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and affect were taken during and immediately following interviews. Participants were
compensated for their time with a $20 gift card.
Data Management
Interviews were transcribed verbatim, cross-checked, and de-identified. We
used the qualitative coding software NVIVO to manage data.
Data Analysis
The results of this study are based on the analytic interpretation of the PI (SA),
with emergent codes and themes discussed throughout the analytic process with all
members of the study team. Analysis of the data began after the first interview was
conducted and included field notes which were analyzed concurrently with the
interviews (Willis, et al., 2016). Field notes were used to add context to audiorecorded interview data and helped refresh the PI’s memory of interview
environments, participant affect, and non-verbal communication. The PI first
“familiarized” herself with the data by carefully reading and re-reading each transcript
and highlighting text that reflected potential codes (Braun & Clarke, 2006). Next she
iteratively generated codes from the data. Once all data were coded, codes were
grouped into themes. After themes were identified, the study team named and defined
the major theme and subthemes (Braun & Clarke, 2006). We clearly identified the
“story” behind each subtheme and how each subtheme adds to the larger whole (Braun
& Clarke, 2006).
We used several techniques to ensure the rigor of this research. Field notes
were taken immediately following the interviews and were used to triangulate data by
adding descriptions of the non-verbal components of interviews, such as participant
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body language and affect, in order to increase credibility and richness of the data
(Nowell, Norris, White & Moules, 2017; Wu, et al., 2016). The PI (SA) engaged in
debriefing with the research team as well as peer researchers in a qualitative research
collective comprised of individuals with experience in qualitative methodology, as
well as with the study team (Abboud, et al., 2017). “Peer debriefing” is a tool that can
help increase credibility (congruence of the participant experience with what is
presented by the researcher) of qualitative research findings (Nowell, Norris, White &
Moules, 2017). Transferability, or ability to generalize study findings to other settings
or populations, is another important concern and was addressed by interviewing a
sample of participants from different disciplines (Nowell, Norris, White & Moules,
2017). Demographic information was collected at each interview in order to describe
the heterogeneity of the sample with regards to age, type of healthcare provider, and
years worked as a healthcare provider. Finally, the PI (SA) engaged in a reflexive
process of recording her reflections during the time period that interviews were taking
place, which provided documentation of the study process (Nowell, Norris, White &
Moules, 2017).
Results
Our analysis yielded one overarching theme and three subthemes. Our
overarching theme is labeled determining “true” pain, and our subthemes are labeled
reliable methods, patient population, and consequences of not getting it right. See
Figure 4.1 for a visual representation of the major theme and subthemes.
Determining “True” Pain
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The overarching theme that emerged from these interviews was the importance
of determining “true” pain. Participants described their process for identifying the
quality of pain that patients were experiencing based on what they felt was appropriate
for the type and severity of injury, consistent with patient behavior and other physical
signs (like vital signs) and not perceived to be fabricated for the purpose of obtaining
opioid medication to abuse or divert. Although patients may report that they are in
pain, providers implied that this did not necessarily mean that they were experiencing
“true” pain:
They say when patients say they’re having pain they’re having pain, it’s the
sixth

vital sign. But, um, what’s difficult is that someone could be saying that they’re

in

10 out of 10 pain, but then, they’re laughing and talking on the phone with

their

friends, their vital signs are completely stable.

Inconsistencies between what patients report regarding their pain and what providers
think patients are experiencing due to the way they behave can cause providers to
wonder if patients’ reports of pain truly reflect their pain treatment needs.
Reliable methods. Providers described what they interpreted as reliable
methods for determining “true” pain. Providers expressed that this was necessary
because possible inflation (or deflation) of pain self-reports meant that a patient’s
rating of their pain was an unsatisfactory measure when used alone. Some providers
acknowledged the ubiquity of numerical scales (like 0-10 pain scales) for rating pain
but reported that they did not think these measures were especially helpful because
they could be easily misreported by patients. Reliable methods to determine pain
included evaluating the type and severity of a patient’s injury, evaluating physiologic
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signs such as vital signs and patient appearance, and watching for inconsistencies
between a patient’s reported level of pain and their ability to function. For example,
providers reported doubting a patient’s report of excruciating pain if that patient was
able to eat, sleep, or socialize with visitors:
If someone’s sitting up in the bed, you know, chomping on potato chips, having
conversations on the phone and they’re telling you—and their vital signs are
rock

solid stable—and they’re telling you that their pain is 10 out of 10, I kind of

have

a hard time believing that.
All providers reported their process of watching for inconsistency between

pain self-report and the aforementioned evaluation criteria, however, they described
different techniques to uncover or validate this inconsistency. The least intrusive of
these techniques involves communicating with patients about the mismatch between
what patients are reporting and what the provider believes the pain level actually is:
I’ll say something like ‘Really? Cuz you seem like you’re really quite
comfortable

sleeping there.’ ‘Oh my pain is 10 out of 10.’ ‘Well, you know I have a

hard time

really grasping that because you’re really—I had to really call your

name 4 or 5

times and then shake the bed before you woke up.’

Some providers reported surveilling patients without their knowledge in order
to see how they behaved when they didn’t know they were being watched:
I try to peek in the room. I don’t let them close the door—on patients who will
want to, you know, get more narcotics—will, you know, play things up,
obviously.
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The most extreme example of a technique used to determine “true” pain involved
physically inflicting pain in order to determine how much discomfort a patient was
truly experiencing. This participant stated:
Sometimes I’ll purposely bump into the bed really hard and move the bed and
see

if they respond. If somebody has their leg broken…I will purposely hit it and if
they don’t flinch. Another thing I’ll do too for somebody who has an extremity
injury in their lower leg is we’ll just push their big toe up, like while I’ll

talking to

them I’ll just suddenly like extend their big toe, and that will flex all

the—it will pull on the tendons in the compartments of their leg, and if they writhe in
pain

then I’m like ok, that’s the real deal. Usually you can distract them and they
won’t respond to it. And you’re like ok, I’m not concerned. Those are the main
things that I usually do.
Only one provider reported this type of behavior, but it falls on the spectrum

of techniques that providers expressed believing were required to reliably determine
“true” pain.
Patient population. Participants expressed that it was especially important for
them to be on guard for manipulated self-reported pain scores and substance
use/diversion because of the characteristics of the population of patients that they
managed in their daily practice. Some participants acknowledged the diversity of
injuries and types of patients seen in their work environment, but many statements
suggest that they believe there are specific behaviors that can be expected of trauma
patients:
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You know, there are some patients who will take their narcotics and sell them,
absolutely. That’s totally a realistic observation that there are patients,
especially

patients in the trauma world, who think, you know, they can get money

for these

pills on the street.

Another participant, referring to patients asking for opioid pain treatment, stated:
You have to be cautious with our trauma patients in this—in the urban setting,
because some of our patients are not narcotic naïve, and they do like to
dictate.
While participants described seeing many patients of different ages with injuries
related to falls or motor vehicle accidents, one acknowledged that violent injuries felt
most prevalent:
It’s an urban trauma center, so although I think our numbers bore out that
roughly half is penetrating trauma, some days it feels like it’s three-fourths to
eighty, ninety percent penetrating trauma. So sometimes it’s a young, urban
population.
Descriptions such as these suggest that some providers had the tendency to
homogenize their patient population and make generalizations about them and their
risk to misuse opioid medications, despite stating, when asked, that their population
was actually quite diverse age and injury-wise.
Consequences of not getting it right. Participants described the negative
consequences of not accurately determining if reported pain was “true” and acting
accordingly: either patients who did not need pain treatment for the current injury
would be prescribed opioids, or patients experiencing pain would be undertreated.
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Provider anxiety about ensuring that they were not “tricked into” prescribing opioids
for fabricated pain was based on fear that these prescriptions would be abused or sold.
Some participants described their relatively recent appreciation of the abuse potential
of opioids with the evolution of the opioid crisis and remarked on how they had not
been trained to consider the potential of substance abuse. However, all participants
had since recognized the risks associated with opioids and were worried about
contributing to the opioid crisis:
You’re always—again, you just don’t know who’s going to turn around and
sell

these prescription drugs on the street. You are, um, you know, you’re helping
provide drugs for people and its—I don’t want to do that. I don’t want to be,

you

know, part of the problem…at the same time, it’s a very fine line, because I

don’t want to not adequately treat my patients’ pain.
Although all providers expressed worry that prescribed opioids could fuel a
patients existing substance abuse or cause a patient to begin abusing substances, two
providers had a slightly more flexible perspective on substance use than the others.
One provider stated:
People may be looking for medication or looking for drugs to use not in the
way or not for the reason that we intend as prescribing providers, but that
doesn’t necessarily mean it’s wrong or the worst thing for them—it may be the
best thing for them in some contexts. But it’s a little hard to navigate.
Another provider echoed this understanding of the complex reasons why individuals
use substances, while also acknowledging how substance use can make pain control
difficult:

113

Basically it’s how you approach them. It’s non-judgmental…‘I’m not your
mom, I’m not the police, what you do, you have to do to get through your day.
I’m just asking you to be honest with me because I don’t want to do anything to
unintentionally hurt you.’
On the other end of the spectrum, other providers openly expressed that they had
difficulty understanding how or why patients might use substances:
I try to be as understanding as I can, but I do come from a family and a circle
of

friends where, like, it’s bad if I take Tylenol, basically. Um, I’ve never had
narcotics in my life well except lidocaine injections for dental work, but not

like,

you know, nothing long term. And, um, most of—yeah, it impacts my view on
things, in that I try really hard to understand and be sympathetic to how they

got

to where they are, um, but it can be a little bit hard for me to relate to

sometimes.

Um, as to like, how did you let it get this far?

Providers also expressed the concern that patients who needed pain treatment
might not receive it. Two concerns emerged: that undertreated pain would have
negative health consequences for patients, and that patients in pain after discharge
would create a hassle for providers. Referring to the negative health effects of
undertreated pain, one participant stated:
We worry about peoples’ pain because pain is bad for people, but we also
worry about their functional limitations which can sometimes be bad for their health,
so

we want people to be able to walk so that they can get around and do the

things that are important in their lives, but we also want people to be able to walk so
that they don’t get DVTs. And when people have rib fractures we want their
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pain

to be controlled so that they are able to breathe well enough so that they won’t
get pneumonia or whatever.

The concern that untreated pain could be especially detrimental for patients with rib
fractures related to respiratory compromise seemed to be a particular concern as it was
mentioned by almost all participants.
Inadequately treated pain after discharge was also perceived as a “hassle” for
providers if patients contact providers after discharge seeking pain treatment:
A lot of it is driven by we don’t want them, in a selfish way, like, when they call
the doc line it’s so painful to call them back and like, listen to these, usually
unreasonable, unreasonable expectations these people have about their pain,
and

they are just yelling at you on the phone, it’s that same conversation, ‘if you’re
that concerned come to the ED.’ It takes, you know 15 minutes of your time

that

you could spend much, much better elsewhere and more efficiently and it’s

better spent doing other things. So even when people say ‘I don’t want narcotics’ I
still

give them a script, I say ‘take the script, don’t fill it unless you want it’ and

that’s it.
Providers acknowledged that this concern could actually lead to more
prescribing, as providers might try to prevent these calls by prescribing more opioids
than they think patients need. Relatedly, a few providers mentioned that some of the
policies enacted to decrease prescribing could have the unintended consequence of
increasing prescribing. An example is the restriction on calling in prescriptions for
controlled substances; since providers know that they won’t be able to easily call in
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orders of opioids for patients who need pain treatment once they are discharged,
providers might prescribe a larger number of pills at discharge:
I mean, I think, uh, healthcare providers have appropriately become much
more conscious of our role in, um, the opiate abuse epidemic, right, and in some
cases have become much more conservative in what we prescribe, but, um, I do
worry about undershooting….I think some well-intentioned regulations can make it
very

challenging because if you want to send someone out with less…it’s also

become

much more difficult to prescribe by phone, it’s harder to send them out

with less

to begin with. So I think sometimes we do send them out with less than

they need,

and they have trouble…or we send them out with more than they should

probably

have to prevent that, which is, neither of those is ideal.
Discussion

The results of this study highlight the multiplicity of factors that providers
consider when planning discharge opioid analgesic prescriptions for patients who have
sustained a serious injury. These participants are aware of the risks associated with
opioids but are also concerned with providing effective and adequate pain control to
their patients. Participants expressed that determining “true” pain was vital due to the
belief that patients might exaggerate or fabricate pain in order to obtain opioid
medications that they can misuse or divert. Providers seemed to believe that this
behavior was fairly common, especially in the population that they treat. These
findings suggest a certain degree of provider distrust with regards to their patients’
motives when they report pain or request pain treatment. It is unclear whether this
dynamic has always existed between these providers and their patients, but it appears
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that increasing awareness of the opioid and overdose crisis has heightened this tension.
One participant noted that the mistrust she often felt when patients requested pain
medication was at odds with what she was taught about good healthcare: that a
provider will trust and believe their patient, and that patients will be able to advocate
for themselves.
Chiarello’s (2015) research explores the shifting of professional roles
consequent to the opioid crisis and the response by governmental, law enforcement,
and healthcare agencies. She writes of providers’ and pharmacists’ use of PDMPs
(which in some states include information about patients’ previous criminal justice
involvement) to determine whether patients are engaging in “doctor shopping” for
controlled substances: “As the regulatory and punitive apparatus designed to deal with
‘street’ drugs shifts into legitimated medical spaces, it has the potential to reorganize
key aspects of health care by privileging punishment over treatment….it requires
health care providers to take on new roles for which they lack training and desire.” (p.
117). Comments about distrusting patient reports of pain and needing to assess
whether patients are attempting to receive opioid medication for abuse or diversion
suggest that providers may be experiencing this role shift to some extent. Although no
participants voiced this explicitly, many noted the discomfort they feel trying to
determine if patients are attempting to “trick” them into prescribing opioids. Instead of
utilizing patient-reported pain severity ratings which are widely used to assess pain,
these participants report resorting to a range of non-verified methods to determine true
pain and the type of pain treatment that patients truly need. This echoes a finding of
Sinnenberg & colleagues’ (2017) that none of the emergency medicine physicians they
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interviewed stated that patient reports of pain were helpful in guiding their pain
treatment decisions. The alternate pain assessment behaviors reported by providers in
our study, especially surveillance and inflicting pain, have the potential to negatively
impact the provider-patient relationship and further deteriorate trust.
Notable in our findings is the providers’ belief that this patient population is
particularly likely to manipulate their pain ratings due to the fact that they are trauma
patients and, as described by many of the participants, “urban.” The hospital at which
these providers work is in a large city, so it is certainly accurate to describe patients
living in the area served by this hospital as urban-dwelling. However, use of the word
“urban” or similar phrases such as “inner-city” to describe people could be interpreted
as coded racialized language that is rarely used for city-dwelling upper-middle class
and/or White populations (Hurwitz & Peffley, 2005; Kooragayala, 2016). Media
accounts of the current opioid crisis have used the words “suburban” and “rural” to
describe (primarily White) subsets of the population impacted by opioid abuse. These
accounts are often sympathetic and suggest that the people and places affected by this
current crisis are not the “usual suspects,” rather, they are often viewed as “innocent,”
“normal” people who were first addicted by overprescribing providers and then taken
advantage of by drug dealers (mostly people of color) who infiltrated their
communities and brought substances from US cities or Mexico (Medoza, Rivera &
Hansen, 2018; Netherland & Hansen, 2016). This is in deep contrast to the
stigmatizing ways in which (primarily Black and Latinx) individuals in urban areas
who used crack cocaine during the early years of the War on Drugs were described
(Medoza, Rivera & Hansen, 2018; Netherland & Hansen, 2016)
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As voiced by the participants, although the trauma service sees a diverse group
of patients and injuries, “some days it feels like it’s three-fourths to eighty, ninety
percent penetrating trauma…it’s a young, urban population.” The use of the word
“urban” and referral to penetrating trauma can be interpreted as a rhetorical strategy to
avoid explicitly racialized language but to nonetheless confer social and racial
meaning (Bonilla-Silva, 2015; Bonilla-Silva, 2018). Participants avoided discussing
race explicitly, and it is possible that they were not fully aware of what their word
choice implied. However, use of this word to describe the demographics of a group of
patients seen at a hospital that is clearly located in a major city, especially in the
context of participants’ belief that these patients were likely to misuse or divert
medication due to the fact that they are “urban,” suggests that participants were
attempting to portray something about their patients beyond the simple fact that they
are city-dwelling.
Our study adds a new perspective to the body of literature about experiences of
injured patients. Other qualitative studies have reported that intentionally injured
Black patients describe feeling stigmatized by healthcare providers due in part to
injury mechanisms like gunshot wounds (Liebschutz et al., 2010; Patton et al., 2016;
Rich, 2009). Although Patton & colleagues (2016) focused on the experiences of
patients rather than providers, they suggest that patients with intentional injuries may
be at particular risk for stigmatization in healthcare settings as providers may assume
that patient choices led to injuries. Providers in our study did not explicitly report bias
against intentionally injured patients, although generalized comments about the patient
population suggest that some may believe that trauma patients are especially likely to
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misuse or divert substances. Even if providers aren’t fully aware of their biases, the
findings of previous qualitative studies suggest that patients feel the impact.
Participants in our study expressed concern about the consequences of some
system and policy level efforts to curb opioid prescribing. Especially notable were
comments about the possibility that regulations controlling electronic and phone
prescribing might result in providers prescribing more opioids than necessary in an
effort to avoid both adverse outcomes for their patients (undertreated pain) and
provider hassles (needing to deal with patients who call with complaints of pain once
they are discharged). This echoes the findings of Habbouche et al. (2018), who
discovered that the rescheduling of hydrocodone (and subsequent limitations on
telephone and facsimile prescribing) was associated with an increase in the number of
pills prescribed immediately after surgery. While new restrictions and guidelines have
helped to address the opioid crisis in important ways, our findings highlight the need
to critically examine the potential unintended consequences of these efforts. Relatedly,
many other researchers, providers, and activists have called attention to unintended
consequences associated with opioid control efforts, including withdrawal following
rapid tapers in opioid maintained patients, purchase and use of opioids (especially
fentanyl) from the street to replace discontinued prescriptions, provider abandonment
of patients deemed too “risky” due to long-term opioid use, and patient suicides due to
uncontrolled and untreated pain (Demidenko, et al., 2017; Dowell, Haegerich & Chou,
2019; Nam, Shea, Shi & Moran, 2017; Rothstein, 2017).
The lack of institutional diversity was a major limitation of our study.
Providers’ pain management choices may be influenced by the other providers at their
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institution and the institutional norms as a whole, especially if they were trained at
said institution. The experiences of providers in our study may also differ from those
of providers who work at institutions in different geographical areas with less violent
crime. As stated by Patton et al. (2016) in their qualitative study focused on injured
Black patients in Chicago (another city with a high violent crime rate), when
discussing trauma provider implicit bias: “The stream of wounded young people may
perpetuate the stereotypes about gunshot victims as gang-members, drug dealers, or
individuals whose lifestyle choices caused their injures.” Future work in this area
should address this issue by recruiting a larger sample of providers from a variety of
institutions and locations throughout the country.
Conclusion
Participants in our study voice numerous concerns related to prescribing opioid
pain treatment to injured patients at discharge. Chief among them is the ability to
determine “true” pain, which is described as necessary to ensure that patients who
need pain treatment receive it, and those who fabricate reports of pain in order to
misuse or divert opioids do not. Participants describe a variety of methods they deem
reliable to determine a patients’ pain level, and believe that these methods are
especially important given the population of patients they serve on their units. The
providers in our study consider the many consequences of misjudging a patients’ pain,
which include both pain undertreatment and unnecessary suffering, as well as
overtreatment and contributing to the opioid crisis.
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Appendixes
Appendix A: Interview Guide
Introduction: Thank you for your participation in this research study. The purpose of
this project is to better understand discharge planning for seriously injured patients
and the transition from inpatient to outpatient pain treatment. To maintain
confidentiality, I will not use your name in the labelling of this interview. Try to avoid
using your name or the names of others during the interview. Additionally, I will use
verbal consent so that you do not need to sign your name on a piece of paper, as this
could jeopardize your confidentiality. You have the right to decide not to participate in
this study at any time, and we can stop the interview at any time if you desire. I will be
audio-recording this interview, and I will be the only person to listen to this recording.
I will destroy the audio-recording once the interview is transcribed. All transcriptions
will be stripped of any identifiers.
1. Tell me about how you evaluate the pain treatment needs of an injured patient
who is soon to be discharged.
2. Tell me about how you communicate with a patient regarding their pain
management at the time of discharge.
3. Other than what has already been described, what other patient factors do you
consider important when you develop a pain treatment discharge plan for a
patient.
a. If participant asks what is meant by “factors”:
i. Are there any patient characteristics that you consider when
developing discharge plans?
ii. Are there ways in which your planning would change due to
individual patient characteristics?
4. What makes you think a patient’s pain is adequately controlled?
5. What makes you think a patient’s pain is not adequately controlled?
6. Have you ever been worried that a patient has left the hospital without what
they needed for pain control?
7. Tell me a situation where you were concerned about prescribing a patient an
opioid at discharge.
a. What made you concerned?
b. How did you handle it?
8. How, if in any way, has attention to the current opioid crisis impacted your
discharge planning?
9. Is there anything else you’d like to add to help me understand the dynamics of
pain treatment discharge planning?
10. Do you have social proximity to substance use and criminal behavior in your
personal life?
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Chapter 5
The aims of this dissertation study were to examine major influences on the
treatment of pain in injured Black patients, to quantitatively describe the factors that
predict receipt of discharge opioid prescriptions in a cohort of seriously injured Black
men, and to qualitatively explore how clinical providers perceive their injured
patients’ pain and need for analgesia when making discharge pain medication
prescription decisions. Initial motivation for this work was prompted by previous
research documenting racial pain treatment disparities. A large number of studies have
demonstrated the existence of these disparities and many have explored possible
reasons why White patients are more likely to receive pain treatment for a wide
variety of conditions than are people of color. The potential impact of intentionality of
injury on receipt of pain treatment has been discussed in previous publications but has
not been explicitly measured quantitatively (Martin, 2000; Neighbor, 2004). This
dissertation adds to previous research by exploring the impact of injury intent on
receipt of pain treatment in a cohort of injured Black men and provider decisionmaking regarding discharge pain treatment for injured patients.
It is possible that injury intent can impact care due to the way that intentionally
injured patients are perceived by providers. “Assumed criminality” refers to the belief
or stereotype that a person or group of people is likely to be involved in crime despite
a lack of firm evidence of illicit activity. Certain types of injuries such as gunshot
wounds may cause providers to believe that patients were involved in some sort of
illicit behavior or at least “did something” to warrant their injuries, which may impact
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the level of empathy they extend towards these patients (Patton, et al., 2016; Rich,
2009). Association with criminal behavior causes individuals to be stigmatized and
disadvantaged in US society (Manza & Uggen, 2004; Pager, Western & Sugie,
2009)—thus, I was curious about how the assumption that a patient is involved in
crime might impact the care they receive. Black individuals, especially Black men, are
more likely than other demographic groups to be assumed criminal in US society due,
in part, to media portrayals that perpetuate a narrative that associates Black
masculinity with deviance (Muhammad, 2011; Oliver, 2003), and a criminal justice
system wherein Black men receive harsher punishments than White men (Alexander,
2010; NAACP, 2018). Although many patients sustain intentional injuries (i.e.,
gunshot wounds or blunt force assault) without any criminal involvement, it is
possible that these patients are less likely to be viewed as “innocent victims” than
patients with injuries due to motor vehicle accidents or falls, especially if they are
already at increased risk of being viewed as criminal due to their race (Rich, 2009).
Assumed criminality may be especially relevant with regards to pain treatment.
The current opioid crisis has alerted providers to the possibility of misuse and
diversion of prescribed medications, and treatment guidelines like the CDC’s implore
providers to consider these potential risks when making prescribing decisions (Dowell,
Haegerich & Chou, 2016). Additionally, pain is subjective and providers do not have a
universally accepted measurement tool for assessment beyond patient self-report, and
providers may underestimate or doubt certain patients’ pain reports (Sinnenberg et al.,
2017; Staton et al., 2007). When used systematically with all patients, tools like
prescription drug monitoring programs (PDMPs) and urine drug screens (UDSs) may
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help decrease the influence of provider bias on prescribing decisions but could have
the opposite effect if providers choose to use them only with certain patients that they
already suspect of misuse or diversion (Chiarello, 2015).
Summary of Results
Chapter 2 set the groundwork for chapters 3 and 4. This mixed-studies
literature review explored the state of knowledge regarding factors that impact the
receipt of pain treatment in injured Black patients. The existing literature suggested
that assumed criminality based on stereotyping and bias, healthcare provider
characteristics, and racial myths about pain sensitization impact provider decisionmaking regarding pain treatment for Black patients. Studies exploring the use of
opioid risk-reduction strategies such as urine drug screens and limited early refills in
chronic pain patients found that Black patients are more likely than White patients to
be subject to these interventions, suggesting that providers believe that they are at
higher risk for substance misuse or illicit activity such as medication diversion
(Becker et al., 2011; Hausmann et al., 2013). Findings from qualitative studies suggest
that injured Black patients, especially intentionally injured Black patients, experience
stigmatization in healthcare settings (Liebschutz et al., 2010; Patton et al., 2016; Rich,
2009). As stated by Patton et al. “the stream of wounded young people may perpetuate
stereotypes about gunshot victims as gang-members, drug dealers, or individuals
whose lifestyle choices caused their injuries” (2016, p. 17). Receipt of pain treatment
may also be influenced by the social identities and belief systems that providers bring
to patient-provider interactions, such as racial and gender identity, sense of empathy,
cognitive load, and by socially and historically constructed myths about pain
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sensitization. Studies of both laypeople and healthcare providers find that beliefs about
biologic differences between races prevail, in particular beliefs about Black people
being less sensitive to pain (Hoffman et al., 2016; Trawalter et al., 2012).
Chapter 3 quantitatively examined the factors that predict the discharge
analgesic prescription, specifically opioid analgesics, in a cohort of seriously injured
Black men. Self-reported substance overuse was associated with reduced odds of
receipt of opioids at discharge, and increasing injury and pain severities and length of
stay (LOS) were associated with increased odds of receipt of opioids at discharge.
Self-reported substance use not characterized as overuse and injury intent (intentional
vs. unintentional) did not impact receipt of opioids. In the subset of patients who
received opioids, increasing pain severity and longer LOS were associated with higher
prescribed doses. Reflecting national trends in opioid prescribing, patients discharged
in the later years of the parent study from which the data originated received lower
doses than those discharged in the earlier years.
Chapter 4 qualitatively explored factors that providers consider when they plan
discharge pain treatment for seriously injured patients. The overarching consideration
that providers described was the importance of determining “true” pain in their
patients, which providers defined as pain that patients were actually experiencing and
was not fabricated for the purpose of obtaining opioids to misuse or divert. Subthemes
of determining “true” pain were reliable methods, patient population, and
consequences of not getting it right. Reliable methods refers to strategies that
providers described through which they sought to determine the extent and veracity of
a patient’s pain. These methods include evaluating vital signs and appearance,
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assessing injury severity, and watching for inconsistencies between a patient’s
reported level of pain and their ability to function. Providers identified all of the
aforementioned as being more helpful than subjective patient-reported pain scale
ratings. Providers reported confronting patients if they did not believe their reported
pain levels were consistent with patients’ vital signs or behavior and surveilling
patients to monitor behavior when patients do not know they are being watched. One
provider reported an extreme approach that involves inflicting pain to determine if a
patients’ pain is as severe as reported. Providers reported that these strategies are
especially important due to the trauma patient population they serve on their units,
which some providers described as “urban.” Finally, providers described concern
about the consequences if there were unable to accurately determine which patients
need pain treatment. A provider might underestimate a patient’s pain treatment needs
and the patient would suffer needlessly, or a provider will prescribe opioids to a
patient who would misuse or divert the medications, both situations that participants in
our study voiced trying to avoid.
Discussion
Taken together, findings from this multi-method study tell an interesting story
about pain treatment for seriously injured patients. I did not find quantitative evidence
that intent of injury impacts receipt of discharge opioid prescriptions. However,
providers in the qualitative study reported a belief that certain characteristics about
their trauma patients suggest that they may be at increased risk of misusing or
diverting opioids, with one provider stating: “there are some patients who will take
their narcotics and sell them, absolutely. That’s totally a realistic observation that there
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are patients, especially patients in the trauma world, who think, you know, they can
get money for these pills on the street.” In addition, some providers used the word
“urban” to describe their patient population, which could be considered racialized
code when used to refer to people (Hurwitz & Peffley, 2005). It is possible that
providers harbor some degree of implicit bias about intentionally injured patients. This
potential bias, however, did not impact opioid prescribing in the quantitative arm of
this study. This may be due to the increasingly protocolized nature pain care as
hospital systems implement guidelines for opioid prescribing (American Hospital
Association, 2017).
It is possible that race and injury intent interact such that intentionally injured
Black patients are viewed differently than intentionally injured White patients,
possibly due to racist media portrayals of Black men as dangerous individuals
particularly prone to violent crime (Muhammed, 2011; Oliver, 2003). However, this is
impossible to discern in a sample comprised entirely of Black men. Implicit bias about
injured Black patients, especially intentionally injured Black patients, is suggested by
the findings of previous qualitative work (Jacoby, 2015; Liebchutz, et al., 2010; Patton
et al., 2019; Rich, 2009). As discussed in Chapter 1, race is socially and politically
constructed rather than biologic (Roberts, 2012; Zuberi, 2003). It is also not
homogenous—the intersections of identities and characteristics such as race, gender,
sexual orientation, ability, skin color, and class can impact the ways that people are
perceived and treated in society and healthcare environments (Crenshaw, 1989; Kendi,
2016).
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Increasing pain scores were associated with increased odds of receiving
opioids at discharge in our quantitative study, which is in line with appropriate acute
pain care (Ng & Cashman, 2018). However, this differs from a finding from the
qualitative study: participants reported that they did not focus on patient-reported pain
scale ratings due to a belief that they were unhelpful measures. Again, it is possible
that providers’ biases about intentionally injured patients lead them to question the
utility of these pain scale self-reports, as patients are able to misrepresent their pain if
they chose. The lack of alternate tools for assessing pain may lead providers to depend
on these scales regardless. It is also possible that continued media attention on the
opioid crisis has changed the way providers think about pain assessment over the past
few years. The parent study data were collected from 2013-2017, and our interviews
took place during December 2018-February 2019.
Notable in the findings described in Chapter 4 was provider discussion about
unintended consequences of regulations intended to reduce opioid prescribing.
Participants in this study mentioned the possibility that providers might prescribe
more opioids at discharge due to the restrictions on telephone prescribing. Habbouche
and colleagues (2018) reported increases in the number of pills prescribed postsurgery after hydrocodone was rescheduled and could no longer be prescribed by
telephone or fax. Hectic work schedules may compound this issue. Providers in this
study voiced that patients with untreated pain after discharge caused “hassles” that
interfered with their work. Unintended consequences such as these and others
described in the literature are examples of why clinicians from across healthcare
disciplines must be involved in the development of health policy. In addition, well-
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meaning policies and regulations implemented to address the opioid and overdose
crisis must be regularly evaluated.
Limitations
All participants of this dissertation study reside in one greater metropolitan
area, Philadelphia. In addition, the cohort of participants examined in Chapter 3 are all
Black men. While this sample allowed me to focus on the discharge pain treatment of
a group of patients who are already at risk of pain undertreatment due to race, I was
unable to compare discharge pain treatment across race and gender. I was also unable
to compare discharge pain treatment across institutions. Likewise, all participants in
the qualitative study worked at the same institution. Providers’ clinical decisionmaking may be influenced by the other providers they work with and institutional and
regional norms more generally. Many hospitals across the US have implemented
taskforces or guidelines to help inform pain treatment decision-making at their
institutions, including the institution at which this study took place (American
Hospital Association, 2017). This may result in similar prescribing practices within
individual hospitals, although practice may differ between institutions.
An additional limitation of the study presented in Chapter 3 is the manner by
which I determined substance use history. I was unable to access substance use related
diagnosis codes from the patients’ medical records due to state regulations. Therefore,
I used self-reported use and overuse data from the parent study research dataset.
Although self-reported substance overuse was associated with lower odds of receipt of
opioids at discharge in this cohort, I do not know if comparable information was

134

available in the medical record and/or if providers were aware of their patients’
substance use when making discharge prescription decisions.
It is possible that Chapter 3 results may have differed if I had conducted this
study before the opioid crisis received major media attention. Providers have become
increasingly careful about opioid prescribing and prescribing rates have decreased
over recent years (Clarke, Skoufalos & Scranton, 2016; Haytham, et al., 2017).
Although it is not a limitation of the study per say, I am curious if injury intent may
have had a different impact on receipt of opioids during a time when they were
prescribed more liberally overall, although in a racially disparate manner.
Implications
The findings of the qualitative study suggest that fears about opioid misuse and
diversion prompt providers to question their trauma patients’ self-reports of pain and
subsequently utilize different strategies to determine if patients are experiencing “true
pain.” These strategies suggest provider suspicion of patients’ reported experiences,
which has the potential to interfere with the patient-provider relationship. Trust is an
important part of a successful patient-provider relationship and trust in providers can
impact patient healthcare engagement and outcomes (Birkhauer et al., 2017). Patients
with occupational injuries report that perceived provider mistrust of their injuries and
need for workers compensation negatively impacted their care experience (Kilgour,
Kosny, McKenzie & Collie, 2015). However, the tangible ways in which provider
distrust can impact care of injured patients remain unclear. The receipt of opioids by
seriously injured Black men in the secondary data analysis was associated with injury
and pain severity and LOS, as well as self-reported substance overuse. These findings
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suggest that provider pain treatment decision-making was mostly focused on the pain
related to the current injury, which is in line with appropriate acute pain care (Ng &
Cashman, 2018). Assuming providers were aware of their patients’ substance overuse,
the findings suggest that they were also impacted by these histories as well, which is
consistent with safer prescribing practices as outlined by the CDC (Dowell, Haegerich
& Chou, 2016).
Future Directions
Future studies should investigate the impact of intent and explore the concept
of assumed criminality more generally with racially, geographically, and gender
diverse samples. Additional work should also explore the experiences of providers
who describe discharge pain treatment for injured patients at a range of institutions in
different geographic areas. The current opioid crisis has necessitated a reevaluation of
opioid prescribing and pain treatment in general. Prescribing rates have decreased, but
providers in the US continue to prescribe more opioids and higher doses than
providers in any other country (CDC, 2018). Given known and pervasive racial
disparities in pain treatment, it is vital that providers, other clinicians, and policymakers are careful not to worsen these disparities in their attempts to curb
overprescribing. Future research should continue to explore pain treatment in the age
of the current opioid crisis and how the resulting policy and clinical changes have
impacted treatment disparities. This body of research may also benefit from an
exploration of how non-prescribing clinical staff like registered nurses impact provider
decision-making. Non-prescribing clinical staff in hospital settings often spend more
time with patients than do prescribing providers, and their perceptions of patients
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might impact provider perception of patients, which in turn has the potential shape
provider decision-making.
It is vital that future research continue to explore the possibility that some
opioid control efforts might actually increase risk in certain populations. There is
evidence that the abuse-deterrent reformulation of OxyContin led to increased
overdose deaths as people transitioned to more lethal and unregulated street drugs
such as heroin (Alpert, Powell & Pacula, 2017). It is possible that provider attempts to
curb prescribing could lead to patient self-treatment of pain with substances purchased
illicitly. This may be especially risky in areas where many street drugs, including
counterfeit opioid pills, are laced with fentanyl (CDC, 2016). Future research should
explore this possibility and the potential for increased overdose deaths as people
attempt to self-treat with an increasingly lethal supply of illicit drugs.

Conclusion
Receipt of discharge pain treatment in a cohort of seriously injured Black men
was associated with severity of injury, severity of pain, LOS, and self-reported
substance overuse. Among patients who received opioids, severity of pain and LOS
were associated with increased prescribed dosages. Though these findings suggest
opioid prescribing decisions aligned with seemingly appropriate clinical criteria,
trauma providers expressed the importance of determining “true” pain in their patients,
because they believed that some patients might inflate self-reported pain scores.
Providers reported using a variety of methods to evaluate whether patients’ reported
pain truly reflected the pain they were experiencing, and believe that these methods
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are especially important given the patient population they treat. Results of this multimethods study paint a complex picture of discharge pain treatment that may be
partially influenced by issues of trust, especially in the age of the current opioid crisis.
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